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Antibiotic resistance is a major health challenge because it limits the treatment options for common 
infectious diseases and will cause 10 million deaths each year after 2050. There is an urgent need 
to reduce the misuse of antibiotics and seek new classes of antibiotics that induce less or no 
resistance. Despite the push for new therapeutics, there has been a precipitous decline in the 
number of newly approved antibacterial drugs due to a limited understanding of how bacteria adapt 
to the chemical stress stimuli. The development of antimicrobial resistance is especially true for 
Gram-negative bacteria that develop resistance to antibiotics readily due to their unique highly 
charged outer membrane. Structurally, the Gram-negative bacteria is highly asymmetric bilayer 
that comprises of an inner leaflet of phospholipids and an outer leaflet of lipopolysaccharides. 
Embedded in the bilayer are outer membrane proteins (OMPs) that form pores to allow passage of 
nutrients and other small molecules through the cell wall. In addition to the outer membrane, the 
Gram-negative bacteria have a thin peptidoglycan layer and an inner phospholipid membrane that 
surrounds the cytosol. All potential small molecules have to navigate through all three layers of 
the Gram-negative bacterial cell wall before targeting the cellular functions. There is, however, 
limited understanding of the chemical specificity, structure, and functional aspects of each layer 
in the cell wall.  To enhance our understanding of the bacterial cell wall, we first developed 
molecular models of ten commensal or human pathogenic bacterial species: Pseudomonas 
aeruginosa, Escherichia coli, Helicobacter pylori, Porphyromonas gingivalis, Bacteroides 
fragilis, Bordetella pertussis, Chlamydia trachomatis, Campylobacter jejuni, Neisseria 
meningitidis, and Salmonella minnesota. Second, we studied the self-assembly of OMPs that in 
some cases form trimers in the outer membranes to perform their function. In the third step, we 
combined the outer membrane models and the OMPs to build a computational screening platform 
 
 
to quantify the transport properties of molecules across a bacterial outer membrane. The goal of 
the computational platform is to provide high-throughput screening of vast libraries of small 
molecules that have the potential of being active antibacterial agents against Gram-negative 
bacteria. A computational platform has merit to producing reliable first-round screening of 
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1.1 Antibiotics Resistance 
The discovery of antibiotics in the last century was one of the greatest achievements in the medical 
world. Before that, a simple scratch may lead to death and infections were the most difficult 
problem to overcome during surgery.1 From the 1920s to the 1980s, many different categories of 
antibiotics were introduced to the market to make some common infections easy to treat.2 
However, we are now at the same point as 70 years ago that infections are becoming harder to treat 
when bacteria can protect themselves from antibiotics, and our most powerful antibiotics are 
becoming ineffective, which is called antibiotic resistance.3-6 Antibiotic resistance occurs when 
microorganisms gain the ability to stop the antimicrobial from working against it. Standard 
treatments are becoming less effective, and infections are becoming harder to treat. Even though 
the occurrence of antibiotic resistance is a natural process, the overuse and misuse of antibiotics 
are becoming the primary reasons for accelerating this process to causes higher patient mortality 
and treatment expenses.7 Consequently, many infectious diseases could no longer being effectively 
treated by available antibiotics. Now, about 2 million people in United States have hospital-
acquired infections, resulting in 99000 deaths per year.8 It has been estimated that by 2050, 10 
million deaths will be caused annually by antibiotic resistance and US$ 100 trillion in losses if no 
action is taken.9 So antibiotic resistance has become one of the biggest threats to human health. 10-
12 
Even though the situation is very serious, the development of new antibiotics has slowed to a 
standstill and cannot catch up with the emergence of resistant bacteria.13-17  The last discovery of 
a new class of antibiotics was in 1987, since then there is a huge void in the history of antibiotics 
development.18 Unfortunately, many major pharmaceutical companies are dropping antibiotics 
development programs now, the development of one FDA-approved antibiotic needs at least 10 
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years and over 1 billion dollars.19 Potential antibiotics need to be screened out from more than 
thousands of small molecules, there is a lack of efficient screening technique, which can help lower 
the investment and find out the most promising candidates.20 The low success rate makes the cost 
higher than expectation, antibiotic resistance develops fast after new antibiotics being introduced, 
which makes antibiotics a short-term drug and profits are also reduced.13, 15, 16. Workable guidance 
of describing how to design antibiotic clinical trials from US Food and Drug Administration has 
been long delayed.21 Even though there are some new antibiotics being introduced to the market, 
physicians would prefer to use them when the worse situation happens because they are always 
worry about the development of new resistance. These factors reduce the enthusiasm and 
motivation of pharmaceutical companies to develop new antibiotics. So now, if we do not take 
actions, we would have to face the same situation that there were no appropriate treatments for 
infections.22-25 
1.2 Mechanisms of Antibiotic Resistance  
To better understand how to overcome antibiotic resistance, it is necessary to know how bacteria 
develop antibiotic resistance. Bacteria, large group pf unicellular microorganisms, which are 
thought to be the earliest life forms on earth.26-28 After a long period of evolution, bacteria have 
gained the ability to adapt to hostile environment and sophisticated mechanisms of resistance to 
some harmful naturally-produced molecules, which are the main source of antibiotics.2 Resistance 
to one molecule can be accomplished by more than one biochemical pathway and bacteria can take 
a variety of mechanisms to defend themselves from harmful molecules.7 To provide a 
comprehensive way of explaining the mechanisms, people have categorized them as 1) 
Modification of Antibiotic Molecule structures, 2) Modification of Antibiotics’ Target Sites 
structures 3) Decreased Antibiotic Penetration 4) Efflux pump to extrude the antimicrobial 
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compound.29 For example, resistance to β-lactams in Gram-negative bacteria is mainly because of 
the effect of β-lactamases, which can break the structure of β-lactams.30-33 In Gram-positive 
bacteria, the resistance is due to the modification of penicillin-binding proteins, which are the main 
target of β-lactams.34-36 Besides these two mechanisms, Gram-negative bacteria have gained 
advanced antibiotic resistance mechanisms due to their unique cell envelop structure, the special 
cell wall prevent the entry of most harmful molecules and this cell wall has a group of proteins 
called efflux pumps, which can pump out some toxic molecules that are in the periplasmic space 
of Gram-negative bacteria.37-42 These advanced mechanisms make infections caused by Gram-
negative bacteria even harder to treat. But this outer membrane and proteins are absent in Gram-
positive bacteria, which explains why most Gram-negative bacteria are more pathogenic. 43-45 
1.2.1 Modification of Antibiotic Molecule structures 
Both Gram-negative and Gram-positive bacteria can produce some specific enzymes that can add 
some chemical moieties to the harmful compound or directly degrade these molecules.29, 46, 47 A 
classic example of adding chemical moieties is aminoglycoside modifying enzymes (AMEs), 
aminoglycoside is a traditional category of antibiotics that can inhibit protein synthesis in bacteria. 
48, 49 AMEs can covalently modify the amino or hydroxyl groups. These modifications lead to 
weaker affinity between the drug and its target due to the steric hindrance, resulting in higher MIC. 
AMEs have become the leading cause of aminoglycoside resistance.50 
In addition to modification, bacteria can also destroy the structure of some harmful compounds. 
This is achieved by β- lactamases, which are able to destroy the amide bond of the β-lactam ring. 
30, 31, 33 In order to prevent the effect of β- lactamases, new β-lactams were introduced to the market 
with less susceptibility to β- lactamases. However, new β- lactamases were also appeared to be 
able to hydrolyze the new β-lactams.32 Now even though people have developed more generations 
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of β-lactams, β- lactamases that can destroy any compounds were also found in bacteria. This is a 
typical example of antibiotic driven adaptive bacterial evolution.51 
1.2.2 Modification of Antibiotics’ Target Sites structures 
Most antibiotics have their specific targets inside the bacteria to take effect by binding to them.2, 
52, 53 To interfere the binding of antibiotics and their targets, bacteria can protect the targets or 
modify the structure of these targets to decrease the binding affinity.54-56 For example, a best-
studied example of target protection mechanism involves tetracycline resistance determinants 
Tet(M) and Tet(O).57-60 They are widely distributed among many different bacteria species. Tet(M) 
and Tet(O) show different ways to protect the tetracycline target in ribosome.61 Tet(M) can directly 
dislodge tetracycline from its binding site in ribosome by forming interaction between the domain 
IV of the 16S rRNA and the tetracycline binding site, the formation of this interaction can also 
change the conformation of ribosome to reduce the probability of rebinding. TetO has the same 
binding site as tetracycline and thus is able to compete with tetracycline for the site to reduce the 
binding of tetracycline.62-64 
Moreover, the structure of target sites can also be altered by bacteria. This process is achieved by 
enzymes. For example, the effect of erythromycin ribosomal methylation genes has been well 
studied. An enzyme encoded by these genes can mono- or dimethylate an adenine residue in 
position A 2058 of the domain V of the 23rRNA of the 50S ribosomal subunit, which is the main 
binding site for macrolides, lincosamides, and streptogramin B antibiotics.65-68  
1.2.3 Decreased Antibiotic Penetration 
As mentioned above, most antibiotics have their intracellular bacterial hit targets. To get into the 
bacteria, antibiotics have to penetrate the bacterial cell wall. The cell wall of both Gram-negative 
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and Gram-positive bacteria can prevent the entry of antibiotics to reach their intracellular targets.69 
It is worth noting that Gram-negative bacteria are becoming resistant to most available antibiotic 
drugs.42, 70 The complicated outer membrane of Gram-negative bacteria was found to be able to 
help them develop antibiotic resistance easily and quickly.71-74 The outer membrane of Gram-
negative bacteria comprises lipopolysaccharides (LPS) as outer leaflet, mixture of phospholipids 
as inner leaflet and outer membrane proteins (OMPs) as pores to allow transport of specific small 
molecules.75, 76 The rigid outer membrane forms the first line of defense, which makes the Gram-
negative bacteria much harder to treat than Gram-positive bacteria. Some hydrophilic antibiotics 
such as β-lactams, tetracyclines and fluoroquinolones are found to be hard to penetrate the 
hydrophobic outer membrane of Gram-negative bacteria.71 Vancomycin, which is another 
example, cannot penetrate the outer membrane of Gram-negative bacteria, so it is ineffective to 
treat infections caused by Gram-negative bacteria.77, 78 
1.2.4 Efflux pumps  
Efflux pumps are proteinaceous transporters found in bacterial cell envelop.79 There are 5 major 
families of bacterial efflux pumps. 1) The major facilitator superfamily (MFS), 2) The resistance-
nodulation-cell division superfamily (RND), 3) The small multidrug resistance family (SMR), 4) 
The ATP-binding cassette superfamily (ABC), 5) The Multi antimicrobial extrusion protein family 
(MATE).80 MFS is mainly found in Gram-positive bacteria and RND is unique to Gram-negative 
bacteria.81 In 1980, scientists found that in E.coli, its efflux pump was able to extrude 
tetracycline.82 Since then, many different kinds of efflux pumps have been identified. Their ability 
to pump toxic compounds out of bacterial cells have become another leading cause of the 
development of antibiotic resistance.37, 80, 83, 84  
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1.3 Current Study of Antibiotics Resistance 
Bacteria mostly develop antibiotic resistance through these 4 mechanisms above. The decreased 
antibiotic penetration was found to be the major difficulty for most antibiotics, which results in 
poor effectiveness of most antibiotics. However, current drug design is largely based on the 
interactions of the molecules with their target sites inside the cells, but the efficacy of antibiotics 
also depends on the influx mediated by membrane lipids and porins85. Since most antibiotics need 
to enter bacterial cells and bind to their target sites, they must be able to penetrate the bacterial cell 
envelope. Hydrophobic antibiotics can take a lipid-mediated pathway and porins-mediate pathway 
is major pathway for hydrophilic antibiotics74.  
There have been number of experimental and computational studies conducted in understanding 
the permeability of bacterial lipid membranes and the selectivity of porins. These high diversities 
of lipid composition and porins types of bacterial outer membranes make huge differences of their 
permeability. Understanding these differences would lead to more targeted antibiotics structure 
design. 
Nikado44 et al. found that some hydrophobic antibiotic such as aminoglycosides, macrolides, 
rifamycins, novobiocin, fusidic acid, cationic peptides are able to penetrate the cell envelop by 
diffuse through the lipids. However, the core oligosaccharide region of bacterial outer membrane 
provides a barrier to hydrophobic antibiotics since it contains 6 to 10 sugars. Bacteria mutants with 
truncated core show high sensitivity to lipophylic agents86.  
Eren85 et al. summarized the substrate specificity of Outer Membrane Carboxylate Channels (Occ) 
of Pseudomonas aeruginosa to help understand how this certain bacterium takes majority of small 
molecules using these channels.  They successfully proved that a carboxyl group in the substrates 
is necessary for them to effectively transport Occ. They also identified the substrate specificities 
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of the two subfamilies of Occ, which includes 9 different porins. These results here revealed the 
complexity of the selectivity of porins and the necessity of understanding it, which also lead to 
rational design of novel antibiotics to fight against Pseudomonas aeruginosa. 
Modi87 et al conducted x-ray crystallography, electrophysiology and molecular dynamics 
simulations to study the outer membrane channels OprP and OprO with high similarity from 
Pseudomonas aeruginosa. They identified the amino acids differences between these two channels 
at the constriction region, which result in very different selectivity of these two channels. Double 
mutants of these two porins were generated to understand the functions of these amino acids in 
determining the channel specificity. These results they provided proposed another promising 
strategy of modifying specific amino acids to obtain desired channel specificity. 
1.4 Overcome Antibiotic Resistance using Computational approaches 
Since the outer membrane of Gram-negative bacteria is the leading cause of antibiotic resistance, 
and it has attracted a lot of attentions of scientists. Understanding the interactions between this 
unique membrane and small molecules is essential to guide the development process of new 
antibiotics. To achieve this goal, many potential candidates need to be tested from some small 
molecules libraries, e.g. Microsource SPECTRUM Collection88, ChemBridge Diversity Set 
Library89, etc. However, the traditional methods have many limitations, and they take longer time, 
which indirectly leads to an increase in cost. To facilitate this process, computational approaches 
should be employed to comprehensively understand the details at the molecular level and screen 
out the most potential antibiotics candidates from these libraries to boost the drug discovery 
pipeline. Even though there are a lot of experiments going on to study antibiotic resistance, there 
are still many misunderstandings and unclear areas about the specific process of antibiotic 
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resistance.5, 9, 11, 29, 46 Most experimental data can only give us macro conclusions, it is hard for 
experiments to explore the detailed information in molecular level.  
Recently, with the development of Computer-aided drug design (CADD), computational 
approaches have been widely used to guide and accelerate the early-stage development of new 
compounds more efficient and cheaply.90-92 Molecular dynamics (MD), which is a computer-based 
simulation method to study chemical systems and provide physical behavior of each atom or 
molecule in the system for nanoseconds to microseconds, can be employed to gain insights into 
the actions of small molecules on bacterial outer membrane or membrane proteins in molecular 
level to help develop robust antibiotics. 93-96 
All-atom MD and Coarse-grained MD are being widely used to perform simulations. All-atom 
MD provides us detailed interactions between each atom but needs more computing resources and 
time, so it is too expensive for all-atom MD to achieve long simulation time and simulate 
complicated systems.97 MD in coarse-grained (CG) level could help achieve longer time scale and 
larger system sizes by merging several atoms into one bead to reduce the degree of freedom so 
that people can explore more complex systems.98 Martini force field is a popular used CG force 
field that provides us a variety of parameters of LPS, membrane lipids, amino acids, proteins, 
solvents and ions.99-104 The details about how MD works will be discussed immediately in the next 
chapter. 
However, when we started, Martini force field did not provide parameters for bacterial LPS. To 
fill this gap, we built force field parameters for 10 different common pathogenic or non-pathogenic 
bacteria, available experimental data was used to validate our CG force field parameters.105, 106 
Proteins were also studied to show the ability Martini force field to reproduce the properties and 
behavior of common membrane proteins.107 After that, we built our CG representation of 
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simulation systems comprising Gram-negative bacterial outer membrane with or without OMPs 
embedded depending on the specific bacteria, target molecule and solvents to explore the 
exhaustive transport behavior of target molecule through the membrane or OMPs into the 
periplasmic space. The thermodynamic and kinetic data of the transport can be obtained by our 
CG molecular simulations as well as the molecule-membrane/molecule-protein interactions. To 
alleviate the burden of building new systems with different bacteria membranes, OMPs and small 
molecules, we made an automatic simulation control algorithm to easily achieve our goals, which 
is a computational automated screening platform that can quickly generate the data for further 
analysis. These parameters of Gram-negative bacteria as well as the computational platform can 
better guide the modification of existing antibiotics, design of new antibiotics and faster the 
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Periole, X.; Tieleman, D. P.; Marrink, S. J., Improved parameters for the martini coarse-grained 
protein force field. Journal of chemical theory and computation 2012, 9 (1), 687-697. 
102. López, C. A.; Rzepiela, A. J.; De Vries, A. H.; Dijkhuizen, L.; Hünenberger, P. H.; 
Marrink, S. J., Martini coarse-grained force field: extension to carbohydrates. Journal of chemical 
theory and computation 2009, 5 (12), 3195-3210. 
103. López, C. A.; Sovova, Z.; van Eerden, F. J.; de Vries, A. H.; Marrink, S. J., Martini force 
field parameters for glycolipids. Journal of chemical theory and computation 2013, 9 (3), 1694-
1708. 
104. Uusitalo, J. J.; Ingólfsson, H. I.; Akhshi, P.; Tieleman, D. P.; Marrink, S. J., Martini coarse-
grained force field: extension to DNA. Journal of chemical theory and computation 2015, 11 (8), 
3932-3945. 
105. Ma, H.; Irudayanathan, F. J.; Jiang, W.; Nangia, S., Simulating Gram-negative bacterial 
outer membrane: a coarse grain model. The journal of physical chemistry B 2015, 119 (46), 14668-
14682. 
106. Ma, H.; Cummins, D. D.; Edelstein, N. B.; Gomez, J.; Khan, A.; Llewellyn, M. D.; 
Picudella, T.; Willsey, S. R.; Nangia, S., Modeling diversity in structures of bacterial outer 
membrane lipids. Journal of chemical theory and computation 2017, 13 (2), 811-824. 
107. Ma, H.; Khan, A.; Nangia, S., Dynamics of OmpF trimer formation in the bacterial outer 







































Understanding the microscopic interactions of atoms and molecules have always been a problem 
in the scientific community due to their tiny size. The basic idea of MD simulation is to calculate 
the interactions between the particles and integrate the equations of motion to explore the 
microscopic properties and behavior of some systems that scientists have interested in.1 Classical 
mechanics, statistical mechanics, thermal dynamics and kinetic theory are being used to obtain the 
microscopic properties and corresponding macroscopic properties can be calculated by sampling 
and averaging the microscopic behavior. 2 
When performing MD simulations, all particles in a specific system can move and interact for a 
fixed period of time, generating the trajectories by solving Newton's equations of motion.3  During 
each step, the position, velocity, acceleration of every particle will be calculated and used to predict 
the next position, velocity and acceleration. By repeating the process for all particles, the dynamic 
evolution of the system can be revealed.4 The potential function, which is also known as force 
field, is used to determine the forces acting on each particle. Potentials are defined to be able to 
reproduce or mimic the structural or conformational changes to study a complex biological 
system.1, 5, 6 
In this chapter, a summary of key concepts and theoretical basis is introduced to clarify how MD 
simulation works. Some commonly used algorithms, sample applications, limitations of MD, 
software and force fields are also discussed briefly.  
2.1 Equations of Motion  
 
The basic idea of MD simulation is to solve the Newtown’s equations of motion. 
                                                      𝐹𝑖 = 𝑚𝑖𝑎𝑖                                                    (1.1) 













=                                                  (1.2) 
The forces acting on the atoms are usually derived from a potential energy. And the potential 
energy function U includes bonded and non-bonded elements as described below7. 






                                             (1.3) 
𝑈 = 𝑈𝑏𝑜𝑛𝑑𝑒𝑑 +  𝑈𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑 
Firstly, we will consider the intramolecular bonding interactions including interatomic distance, 

















𝛷,𝑚(1 + cos (𝑚𝛷𝑖𝑗𝑘𝑙 − 𝛶𝑚)𝑚𝑡𝑜𝑟𝑠𝑖𝑜𝑛                             (1.4) 
Bonds typically involve the separation rij = | ri − rj| between adjacent pairs of atoms and a harmonic 
form with specified equilibrium separation, the bend angle θijk are between continuous bond 
vectors such as ri − rj and rj − rk, the torsion angles Φijkl are defined in terms of three connected 
bonds. The torsional potential typically involves an expansion in periodic functions of order m = 
1, 2, . . . 
Non-bonded interactions include Van der Waals Potential and electric potential energy. 
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The first term describes the Van der Waals repulsive and attractive interatomic forces in the form 




Now the force can be calculated using equation 1.3 when total potential energy is defined and 
known. Together with the Taylor series expansions8: 
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2                                 1.7   
1.6 + 1.7: 










we can get 





where r is the position, v is the velocity (the first derivative with respect to time), a is the 
acceleration. −𝑟𝑖(𝑡0 − 𝛥𝑡) is the position at (𝑡0 − 𝛥𝑡), 𝑟𝑖(𝑡0) is the positions at 𝑡0, 𝑎𝑖 is the 
acceleration at 𝑡0.  
𝛥𝑡 is an important parameter that we define in MD simulations that is known. Mass of atom or 
particle is known from periodic table of elements. Acceleration can be obtained from equation 1.1 
because force is known when potential energy is defined. When starting a MD simulation, the 
initial configuration tells us the initial 𝑟𝑖(0), the distribution of velocities for all atoms at a certain 
temperature we pre-set follow the Maxwell–Boltzmann distribution, which predicts the most 
probable and average velocity.9 So after 𝛥𝑡, all atoms’ new position, net force, velocity and 
acceleration can be determined. By defining the total simulation time, this step will be repeated 




2.2 Force fields 
For MD simulations, force fields provide potential functions mentioned in equation 1.3 and 
parameter sets used in the potential functions to obtain the interactions between the atoms or 
coarse-grained molecules in the systems.10 For most force fields, the parameter sets of potential 
energy can be derived from experimental data and quantum mechanics. There are many different 
force fields available now, such as OPLS (the Optimized potential for liquid simulation)11, ECEPP 
(the empirical conformational energy program for peptides)12, AMBER (assisted model building 
with energy refinement)13, 14, CHARMM (chemistry at Harvard molecular mechanics)15, 
GROMOS (GROningen MOlecular Simulation force field)16, Martini coarse grain force field17, 
etc. Different force fields may differ in many aspects and also at different levels. These force fields 
were developed by different research groups and each force field has their own emphasis on 
specific biomolecules or systems. They all show different performance of simulating proteins, 
organic solvents, solvents, nucleic acids, etc. Because the research groups who developed force 
fields have their own research interests, the force fields were tuned for specific types of problems. 
They are also compatible with different software. So the choice of force field depends on the actual 
simulated system.18-20 Most force fields can be classified into two types: All-atom force field and 
Coarse Grain force field.  
2.2.1 All-atom force field 
All-atom force field, as the name suggests, provides parameter sets for every single atom in a 
system. GROMOS force field, which is an All-atom force field, was developed at University of 
Groningen and Swiss Federal Institute of Technology. GROMOS force field is suitable to simulate 
most small molecules, solvent and proteins. It can also be easily covert to coarse grain force field. 
The potential functions of GROMOS force field is described as equation 1.4 and 1.5, which apply 
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to most All-atom force fields even though they have different parameter sets from different sources 
used in these potential functions.16 Some other all-atom force field hydrogen bonding potential 
like AMBER force field.13 All-atom force field describes the detailed intermolecular and 
intramolecular potential, so it provides accurate behavior of all atoms and molecules in a system. 
However, due to extensive calculations of all-atom force fields, they cannot be applied to large 
biological systems (> 100 nm) and some biological phenomenon that cost more than 100 ns.21 
2.2.2 Coarse grain force field 
Coarse-grained force field, on the contrary, is widely used in long-time simulations of 
macromolecules such as lipids, sugars, sterols, polymers, proteins, nucleic acids, and multi-
component complexes. The MARTINI force field, which was developed by Marrink and 
coworkers at the University of Groningen.17 After 2007, MARTINI force field was extended to a 
variety of biomolecules that we needed to use in my work.22-27 
MARTINI force field is one of the most popular coarse grain force field now. Based on all-atom 
force field, MARTINI force field employs certain rules to coarse grain the atoms, on average 3 to 
4 heavy atoms are mapped into one MARTINI coarse grained (CG) bead. This mapping reduces 
the number of particles being simulated in a system and also the degree of freedom to reduce the 
amount of calculations.  
To accurately reproduce the interatomic and intraatomic interactions from all-atom force field, CG 
beads in Martini force field are classified into 4 major types and 18 subtypes: polar (P), nompolar 
(N), apolar (C) and charged (Q). Each major type has its own subtypes to represent specific 
chemical units or functional groups based on their polarity. The combination of these 18 subtypes 
can represent a lot of biomolecules. Because hydrogens are ignored in coarse grain force fields, 
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based on the ability of forming hydrogen bonding, some functional groups can be divided into 4 
kinds: d (donor). A (acceptor), da (both) and 0 (none).  
MARTINI force field still uses similar bonded and non-bonded potential energy described in 
equation 1.3, 1.4 and 1.5. Comparisons of MARTINI force field and some other all-atom force 
fields have been done to verify the ability of MARTINI force field to reproduce the accurate 
behavior of lipid bilayers, formation of vesicles, bacterial lipopolysaccharides membrane, etc. The 
simplified CG model helps MARTINI force field to perform simulations of large systems ( > 100 
nm) and longer time scale (> 100 ns), which is the best choice for my work to study the behavior 
of complex membrane and proteins.28-31 
2.3 Ensembles 
 
In MD simulations, sometimes we have to keep some variables of the system constant to mimic 
the real experimental conditions. Different statistical ensembles can be generated by controlling 
the energy E, volume V, temperature T, pressure P, and number of particles N. After fixing one or 
more variables mentioned above, structural, energetic, and dynamic properties can be obtained 
based on the averages or the fluctuations of these fixed and unfixed variables. The most common 
used ensembles in my study are NVT (constant number of particles, constant volume, constant 
temperature)32 and NPT (constant number of particles, constant pressure, constant temperature)33. 
NVT ensemble, also known as the canonical ensemble, the volume and temperature are fixed 
during the simulation process. NVT ensemble can be obtained using direct temperature scaling at 
the initialization stage and temperature-bath coupling during the simulation to control the system 
temperature. Volume is always fixed during the whole process. NVT ensembles are mostly used 
when performing conformational searches of molecules in vacuum regardless of defining volume, 
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pressure, and density. In this condition, pressure is not a significant factor and NVT could provide 
the advantage of less perturbation of the trajectory without coupling to a pressure bath. 
NPT ensemble, known as isothermal-isobaric ensemble, the temperature and pressure are fixed 
Isothermal-isobaric ensemble controls both temperature and pressure, which applies to most cases 
of my study when pressure is an important factor and one atmosphere is always used to mimic the 
realistic condition. In NPT ensemble, the volume of simulation systems is allowed to change to 
adjust the pressure to preset value. This ensemble considers correct pressure, volume, and densities 
are important factors. NPT ensemble can also be used to obtain another NVT ensemble when 
desired temperature and pressure are needed to be achieved. 
To achieve desired temperature and pressure, external heat and pressure bath controls are supplied, 
they are also known as “thermostat” and “barostat”.34, 35 There are many frequently-used 
thermostat and barostat, such as Nosé-Hoover Thermostat36, Parrinello-Rahman barostat37, 
Anderson Thermostat38 and Berendsen thermostat/barostat39, etc. They have their own advantages 
and disadvantages in different situations.  
The choice of thermostat and barostat depends on the actual situation and the original design 
purpose of these algorithms. These methods were designed based on specific systems. Based on 
other people’s experience and the systems I was studying, Berendsen thermostat and Berendsen 
barostat were most frequently used to control the temperature and pressure as recommended by 
the force field I was using and can be widely used for different systems. Another important reason 
is the potential energy of the coarse-grained force field I was using was developed to take into 
account the suitability of these types of thermostat and barostat. Some tests have been down to 
prove the good performance of these two methods to achieve desired temperature and pressure 
with less fluctuations.  
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2.3.1 Berendsen thermostat 
Berendsen thermostat is a coupling to an external ‘heat bath’ with given temperature TD. The 
function of the heat bath is to compensate for missing or removed excess energy for the system. 
The rate of change of the actual temperature TA is related to the preset temperature. 






                                                          1.8 
Based on the equation above, the effect of Berendsen thermostat is that a deviation of the system 
temperature from initial TA is slowly corrected to the desired temperature TD. τ is a time constant 
meaning the strength of the coupling between the system and the heat bath and should be preset 
before starting a simulation, also known as relaxation time. 
The temperature change between successive steps based on equation 1.8 is  
                                                           ∆𝑇 =
∆𝑡
𝜏
(𝑇𝐷 − 𝑇𝐴)                                                     1.9 
 A factor λ is defined as: 






− 1)]                                                  1.10 
Because the temperature of a system is corresponding to its kinetic energy, or velocity. So the 
temperature of the system can be adjusted by scaling the velocity by the factor λ defined in equation 
1.10. 
𝑣𝑛𝑒𝑤 = 𝑣√𝜆 
Based on experience before, when 
∆𝑡
𝜏
 = 0.0025. a good performance of Berendsen thermostat can 
be achieved. 
2.3.2 Berendsen barostat 
Similar as thermostat, a system can be coupled to an external ‘pressure bath’ with given pressure 
PD when using NPT ensemble. Now, the atomic coordinates and the box vectors are rescaled at 
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each step instead of velocity in temperature coupling. It has the effect of a first-order kinetic 
relaxation of the actual pressure PA towards a given pressure PD by  






                                           1.11 
The rescaling of atomic coordinates and the box vectors are achieved by a factor μ, which is 
defined as  
                                                                  𝜇𝑖𝑗 = 𝛿𝑖𝑗 −
Δ𝑡
3𝜏
𝛽𝑖𝑗(𝑃𝐷 − 𝑃𝐴)                                            1.12  
Here δij is the Kronecker delta, τ is the pressure coupling time constant time constant and β is the 
isothermal compressibility of the system, which can be obtained from experiments. For example, 
when water at 1 atm and 300 K, β = 4.6 × 10−10 Pa−1 = 4.6 × 10−5 bar−1. These two parameters 
must be set before starting the simulation.  
2.4 Energy minimization 
In MD simulations, the stable conformers of a system is necessary to perform the simulations and 
understand the microscopic and macroscopic properties. When building simulation systems using 
some computational chemistry software packages, the initial geometries are always not at the 
stable state, some high energy conformers exist due to the molecular overlap, unreasonable 
structure, etc. These high energy conformers can cause the simulations to terminate. In order to 
remove these bad structures to get the stable conformers and normal simulations run, energy 
minimization is performed before normal simulations. 40-42 
Steepest descent algorithm is being used widely to energy-minimize the initial configuration. It 
can remove some molecular overlap, bad contacts and adjust bond lengths and angle to suitable 
values to create a relatively low energy initial conformation. The basic idea of steepest descent is 
to find the net force in the systems based on the potential energy, then moving in the direction of 
the force, just like walking straight down the hill in a geographical contour to find the conformer 
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with lowest energy. The direction is determined by the maximum force between atoms. So from 
the initial configuration, the system can quickly get rid out of the conformer with highest energy. 
Each step, the new maximum force will be determined and the searching direction is changing 
with the maximum force, by repeating the process, the maximum force is becoming smaller and 
smaller until a preset threshold is achieved or close to zero, then the configuration at this moment 
can be used as the starting configuration for next normal MD simulations.43, 44 
2.5 Software to perform MD simulations: GROMACS 
GROningen MAchine for Chemical Simulations (GROMACS) is a computational molecular 
dynamics software package that is being used widely in the world.45 It was developed by 
Biophysical Chemistry department of University of Groningen in 1991, and now it is maintained 
by global universities and research centers. GROMACS is free and open-source software and one 
of the most popular package for performing MD simulations for biological systems, such as 
proteins, lipids, solvents, DNA/RNA and polymers.46 After years of development and update, a 
rich set of calculation types, preparation and analysis tools are provided by GROMACS.44, 47 After 
version 5, it is updated with several new and enhanced parallelization algorithms to significantly 
improved computational efficiency.48 Moreover, Martini force field, which was developed in the 
same university, uses the GROMACS infrastructure to implement coarse-grained physics models 
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Lipopolysaccharides (LPS) are vital components of the outer membrane of Gram-negative 
bacteria, and they act as extremely strong stimulators of innate immunity in diverse eukaryotic 
species. The primary immunostimulatory center of the LPS molecule is lipid A—a disaccharide-
bound lipophilic domain. Considering the broad diversity in bacterial species, there are variations 
in the lipid A structure and their immunogenic potency. In this work, we model the lipid A 
structures of eight commensal or human pathogenic bacterial species: Salmonella minnesota, 
Neisseria meningitidis, Porphyromonas gingivalis, Campylobacter jejuni, Bordetella pertussis, 
Helicobacter pylori, Bacteroides fragilis, and Chlamydia trachomatis. The membrane properties 
of lipid A from these bacterial species were characterized and compared using molecular 
simulations. Molecular and structural insights provided reveal the diversity of in bacterial outer 





3.2 INTRODUCTION  
 
Gram-negative bacteria have evolved to protect themselves from hostile environments by 
developing a protective outer membrane.  Primary component of the outer membrane are the 
lipopolysaccharide (LPS) macromolecules that due to their unique chemical structure provide a 
negatively charged envelope around the bacterial cell.1 The LPS has three distinct domains—lipid 
A, core oligosaccharide, and O-antigen polysaccharide. Although all three domains have integral 
roles in the outer membrane, the amphiphilic lipid A domain plays a key role in anchoring the LPS 
to the membrane via its hydrophobic interactions.2 
Additionally, lipid A is a well-established endotoxin that stimulates innate immunity in diverse 
eukaryotic species.3 Lipid A is highly conserved among bacterial species, and due to its distinctive 
molecular structure it is recognized as a pathogen-associated molecule by Toll-like receptor 
4/myeloid differentiation factor 2 (TLR4/MD2) present on host immune cells.4 As a response to 
lipid A, the host cells secrete pro-inflammatory cytokines to neutralize the bacteria and their 
endotoxic effects.  
Structurally, lipid A molecule consists of a hydrophilic 1,4′-bisphosphorylated disaccharide head 
and variable numbers of saturated fatty acid tails (Figure 3-1). The head unit consists of 
hydrophiphic β(1→6)-linked D-glucosamine disaccharide head group with α phosphate group at 
position 1 of the proximal, reducing glucosamine residue (GlcN I) and an ester bound phosphate 
group at position 4′ of the distal, non-reducing glucosamine residue (GlcN II). The hydrophobic 
tails comprise of four primary (R)-3-hydroxyacyl residues (labeled A, B, C and D) at the positions 
2 and 3 as well as 2′ and 3′ via amide or ester linkages, along with four secondary fatty acid 
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chains (A', B', C' and D'). The –R functional group (at position 6′) is the binding site of core 
oligosaccharide domain. 
 
Figure 3-1. Lipid A template structure.  
Despite the well-defined structural template, lipid A structures vary among bacterial species. 
Furthermore, to evade detection by the host immune system, bacteria undergo subtle modifications 
to alter their quintessential primary lipid A template—in terms of glucosamine head group, degree 
of phosphorylation, presence of phosphate substituents, as well as the nature, number, location, 
and length of acyl chains.5,6 Often these structural modifications are employed as an active 
response to changing environmental chemical stresses.7, 8 The structural modifications directly 
44 
 
affect pathogenesis by changing outer membrane permeability and promoting resistance to 
antimicrobial peptides. There is therefore, a need to understand structure property relationships 
between the lipid A structures and the properties they confer to the outer membrane of a bacterial 
species.  
Experimental characterization of LPS remains challenging due to the complexity and 
heterogeneity of the bacterial membrane. The isolation of a LPS macromolecule is non-trivial 
considering the amphiphilic nature of lipid A that causes the formation of micelles. Determination 
of high-resolution LPS structure requires iterative extractions followed by refinement and 
fragmentation. Such advances in extraction methods coupled with improved characterization 
techniques such as mass spectrometry (MS), matrix-assisted laser desorption/ionization (MALDI) 
and electrospray ionization (ESI) have been invaluable. In order to expand beyond experimentally 
determined static structural properties of these lipids, complementary computational approaches 
are now being employed to assess the dynamical and thermodynamical properties of the bacterial 
membranes.  
Molecular simulations have become an indispensable tool to understand both the dynamic and 
nanoscale organization of bacterial membrane structures. Although multiple computational 
techniques have been employed to investigate these membranes, coarse-grain representation 
provides an equitable balance between (1) the complexity and chemical specificity of membrane 
lipids and (2) the length and timescales required to characterize these systems.9-11 In our previous 
work, we adopted a multiscale approach to bridge atomistic and coarse-grained representations by 
developing force field parameters for Pseudomonas aeruginosa LPS macromolecule.9 
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In this work, we extend the MARTINI force field parameters10 for a library of eight commensal or 
human pathogenic Gram-negative bacteria species: Helicobacter pylori, Porphyromonas 
gingivalis, Bacteroides fragilis, Bordetella pertussis, Chlamydia trachomatis, Campylobacter 
jejuni, Neisseria meningitidis, and Salmonella minnesota. After 80 independent simulations and 
close to 150 µs of total simulation time, this library of representative bacterial lipids, provides an 
excellent example of the structure-property relationship of lipid A structural modifications and the 
impact they have on the bacterial outer membrane properties. The results highlight the role of acyl 
chain lengths, number of chains, and phosphorylation state in regulating the phase transition 
temperature of the membrane, along with the role of membrane composition and charge of the 
counterions on membrane permeability. Prior to discussing the results, the background information 
on the eight bacterial species, their differences in preferred habitat, and lipid A structure (Table 3-
1) are briefly discussed. 
Table 3-1 Summary of chemical structure of lipid A in various species of Gram-negative 
bacteria. Labels A, A', B, B', C, C', D, and D' correspond to acyl chains shown in Figure 3-1. 






Helicobacter pylori  
H. pylori are spiral, rod-shaped bacteria that live in the upper gastrointestinal tract. It is associated 
with a variety of gastrointestinal diseases such as peptic ulcers, gastric adenocarcinoma and can 
lead to stomach cancer.12 H pylori infection is found in over 50 percent of the world's population, 
especially among the young, and is transmitted through direct human contact. H. pylori can often 
be a lifelong infection in many of its hosts. The outer cell membrane of H. Pylori is similar to that 
of other Gram-negative bacteria. The temperature range supporting H. Pylori’s growth is 307 K to 
313 K, with the optimum temperature being 310 K, which is the average temperature of the human 
body. The chemical structure of its lipid A has glucosamine β-(1-6) disaccharide with phosphate 
at position 1 and four acyl chains (Figure 3-2). The acyl groups are (R)-3-hydroxyoctadecanoic 
acid, (R)-3-hydroxyhexadecanoic acid, and (R)-3-(octadecanoyloxy)octadecanoic acid at the 2-, 3- 




Figure 3-2. Atomistic structure of Helicobacter pylori Lipid A. 
Porphyromonas gingivalis  
P. gingivalis is a non-motile, Gram-negative, endotoxic, anaerobic bacillus of the phylum 
Bacteriodetes found in gingival tissue and in atheromatous plaque and thrives best at 310 K. It is 
a suspected periodontal pathogen because it produces collagenase; however, about 25% of people 
without periodontitis test positive for P. gingilvalis, while 21% of patients with periodontitis test 
negative for P. gingivalis.61 The chemical structure of its lipid A comprises a hydrophilic β-(1,6)-
linked D-glucosamine disaccharide head that is monophosphorylated at position 1, and the 




Figure 3-3. Atomistic structure of Porphyromonas gingivalis Lipid A. 
Bacteroides fragilis 
The anaerobic bacteria B. fragilis is part of the normal microflora of the human large intestine. It 
is the most frequent cause of abdominal and wound infection post-surgical procedures of the 
gastrointestinal or urogenital tract. B. fragilis is a unique enterobacteria with low endotoxicity, 
primarily attributed due its monophosphorylated lipid A that has five acyl residues, which are 
relatively long chains, each with 15-17 carbon atoms (Figure 3-4). The (R)-3-
hydroxyhexadecanoic acid and (R)-3-hydroxypentadecanoic acid residues are present at the 
positions 3' and 3 of the distal GlcN and reducing GlcN groups, respectively. The amino group at 
3' position carries (R)-3-(13-methyltetradecanoyloxy)-15-methylhexadecanoic acid and the pne at 




Figure 3-4. Atomistic structure of Bacteroides fragilis Lipid A. 
Bordetella pertussis 
B. pertussis causes pertussis, a highly contagious respiratory infection commonly known as 
whooping cough because of the characteristic sound patients make when they inhale. Transmission 
between people most commonly occurs by coughing or sneezing.  Its lipid A structure contains a 
common bisphosphorylated disaccharide head group with hydroxytetradecanoic acid in the amide 
as well at the 3′ position (Figure 3-5).17 The shorter acyl chains enable bacteria to escape the 




Figure 3-5. Atomistic structure of Bordetella pertussis Lipid A. 
Chlamydia trachomatis  
C. trachomatis is the most common cause of sexually transmitted bacterial infection, with more 
than 90 million new cases annually worldwide.18 C. trachomatis also is a cause of pelvic 
inflammatory disease in women, increases transmission of HIV, and is a significant cause of 
blindness in the developing world, where treatment is largely absent. Members of the Chlamydiae 
genus are obligate intracellular parasites, and C. trachomatis is specifically reliant on human cells 
to carry out its life cycle. The physiological effects of C. trachomatis, like all Gram-negative 
bacteria, are invoked by its lipid A component. Mass spectrometry shows that the LPS of C. 
trachomatis is composed mainly of a glucosamine disaccharide with five-fatty acid chains and one 
phosphate head (Figure 3-6). The long fatty acid chains of C. trachomatis (up to 21 carbons) are  
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anomalous to most Gram-negative bacteria lipid A components, and is thought to bring about its 
relatively low toxicity.19,20  
 
Figure 3-6. Atomistic structure of Chlamydia trachomatis Lipid A. 
Campylobacter jejuni  
C. jejuni is a microaerobic strain of proteobacteria with a helical shape. It is primarily responsible 
for food borne bacterial gastroenteritis.21 C. jejuni is often found in animal feces and is transmitted 
easily between animals and humans. Its capacity to form a biofilm increases the survival of C. 
jejuni under detrimental conditions; when in a biofilm, the bacteria is one-thousand times more 
resistant to disinfectants.22 The structure of C. jejuni lipid A is similar to others studies in this 
work, except that one of the glucosamine residues of the lipid A backbone is replaced by of a 
GlcN3N monosaccharide, a phosphorylated 2,3 diamino-2,3-dideoxy-D-glucose (GlcN3N) 




Figure 3-7. Atomistic structure of Campylobacter jejuni Lipid A. 
Neisseria meningitidis  
N. meningitidis is a leading cause of bacterial meningitis and sepsis worldwide.23 Meningococcal 
LPS has a bisphosphorylated disaccharide head group with 12:0(3-OH) acyl chains bound to each 
of the two hydroxyl groups at positions 3 and 3', and 14:0(3- OH) acyl chains linked to the amino 
groups at positions 2 and 2', and the hydroxyl groups of the amide-linked chains acylated by 12:0  
carbon tails.24 Additionally, O-phosphorylethanolamine residues cap the phosphates at positions 




Figure 3-8. Atomistic structure of Neisseria meningitides Lipid A. 
Salmonella minnesota   
Typically S. minnesota, the second leading cause of intestinal infections, is transmitted through 
ingestion of contaminated food. S. minnesota infection commonly occurs in the intestinal tract and 
is associated with bloody diarrhea, abdominal cramps, and other related symptoms. Most 
Salmonella serotypes are able to grow and thrive in environments whose temperature falls between 
280 K to 321 K. S. minnesota lipid A has a typical 1,4′-bisphosphorylated disaccharide head  group 
with seven acyl chains that are 12–14 carbons in length. Position 2 and 3 have (R)-3-hydroxy fatty 
acids and 2' and 3' have (R)-3-acyloxyacyl residues. Additionally hexadecanoic acid and 
dodecanoic acid residues are on the (R)-3-hydroxytetradecanoic acid at positions 2 and 2', 




Figure 3-9. Atomistic structure of Salmonella Minnesota Lipid A. 
3.4 METHODS 
3.4.1 Parameterization 
The coarse-grain parameterization of the library of eight lipid A molecules is developed on the 
Martini many-to-one mapping approach,10 and in most cases four heavy atoms are mapped into 
one bead. The structural similarities in the disaccharide head groups and the dissimilarities in the 
phosphorylation state and acyl chain patterns have been incorporated in the parameterization (see 
Table 3-1). The proximal reducing (GlcN I) and non-reducing (GlcN II) glucosamine residues 
were mapped individually to four beads with bead types ranging from P1–P4, based on the number 
of hydroxyl groups. The phosphates at positions 1 and 4′ were assigned a Qa bead type with a unit 
negative charge. The beads linking the acyl carbon chains via amide or ester linkages at positions 




linked to the phosphates were assigned Qd bead type. The acyl chain beads were assigned C1 bead 
type. Figure 3-10 shows the CG mapping of N. meningitidis with bead assignments for the 
disaccharide head group and six acyl chains. For the remaining lipids in the library, the CG 
mapping of the acyl chains is also depicted in Figure 3-10.  
Monovalent (Na+) or divalent (Ca2+) counterions were used to make the systems electrically 
neutral. This ion parameterization accounts for the first hydration shell around the ion, and both 
ions were assigned the Qd bead type. As in our previous work, no additional parameterization of 






Figure 3-10. Coarse-grained mapping scheme for lipid A tails of (A) N. meningitidis, (B) H. pylori, (C) P. gingivalis, (D) B. fragilis, 
(E) B. pertussis, (F) C.trachomatis, (G) C. jejuni, and (H) S. minnesota. The bead types are shown in bold.
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3.4.2 Simulation and analysis details 
Eight sets of simulations, which include variation of membrane composition, membrane size, 
solvent, counterions, and temperature were performed for each of the eight membrane systems 
(Tables 3-2 and 3-3). The simulations were performed using the molecular dynamics engine 
GROMACS, version 5.1.2. The workflow of the simulations involved the initial construction of 
membrane, energy minimization, short isothermal-isochoric (NVT) and isothermal-isobaric (NPT) 
equilibrations runs, and long-production NPT runs.  




Table 3-3 System Details of the Membrane Simulations Involving a Complex Composition of 
the Inner Leafletα 
 
For each simulation run, the membrane was built using a python script, which is a locally modified 
enhanced version insane, a versatile membrane-building tool routinely used in constructing coarse-
grained membranes.  The library of eight bacterial lipids have been coded in the freely distributed 
insane script programmed in python. The workflow of the insane script was not changed from the 
published version. The command line syntax for building the membranes, and the associated 
topology files are provided in the Supporting Information.  
The outer leaflet of the membrane is a mixture of lipid A and 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine (DPPE) in 9:1 ratio for all seven sets. For the inner leaflet either a pure 
DPPE (Sets I-V) or a mixture of DPPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 
(POPE), and Cardiolipin (CDL2) in the ratio 7:2:1 (Set VI-VII) was used. POPE and CDL2 lipids 
have −1 and −2 change, respectively. In generating the membranes, the total number of acyl chains 
in the inner and outer leaflet were kept the same to avoid unphysical bending of the membrane. 
The membranes were solvated with either standard water (W) or polarizable (PW) Martini water 
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as specified (Table 3-2 and 3-3). All systems were made charge neutral by adding Na+ or Ca2+ 
counterions. Details of the solvent, number of ions, and membrane composition are provided. 
Periodic boundary conditions were applied in all three dimensions. 
Energy minimization was performed using the steepest-decent algorithm with a 20 fs time-step 
until the maximum force on any bead was below the tolerance parameter of 10 kJmol−1nm−1. The 
NVT and NPT simulation runs were performed for 0.2 µs. The production simulations were run for 
at least 2 µs and up to 10 µs in some cases (Table 3-2 and 3-3) with a 20 fs time-step. Semi-
isotropic pressure coupling was used, and systems were maintained at 1 bar using the Berendsen 
barostat with time constant, τp = 4.0 ps. Temperature was maintained at 310 K by independently 
coupling the lipids and solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The 
heating scans were performed for a wider temperature range, varying from 275–360 K (Table 2 
and 3). The neighbor list was updated every 25 steps using a cutoff equal to 1.4 and 1.2 nm for 
short-range van der Waals and electrostatic cutoff, respectively. For simulations with polarizable 
water, PME was used for the long-range electrostatics, with an electrostatic screening constant 
εr = 2.5. 
The structural and dynamic properties of the membranes were compared by computing area per 
lipid, membrane thickness, density profiles, order parameters, and phase transition temperatures, 
and diffusion coefficients. The membrane microstructure was quantified by the average area per 
lipid (AL) and membrane thickness (DM), and hydrophobic thickness (DH). For bacterial 
membranes, the AL values was computed by dividing the cross-sectional area of the membrane by 
the number of lipid A molecules in the leaflet. Standard utilities available in the GROMACS 
software suite were employed for all the quantities described above. To determine Tm, the 
characteristic  phase-transition temperature values for the model systems, we performed annealing 
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simulations starting from well-equilibrated configurations to mimic phase transition conditions. 
The heating scans were performed over the 275–360 K temperature range with intermediate 
temperatures of 292, 309, 326, and 343 K and 2 µs of simulation time. 
 
3.5 RESULTS  
3.5.1 Bonded parameters 
The bond distances and bond angles analysis for all eight bacterial lipid A membranes was 
performed using an identical protocol. For the ease of comparison, the lipid A analysis was divided 
into two parts-the head group and acyl chains. Given that the proximal reducing (GlcN I) and non-
reducing (GlcN II) glucosamine residues in the lipid A head group are the same or slightly different 
(in C. jejuni) in the eight bacterial lipids, the average bond distance frequency distribution is very 
similar (Figure 3-11). A unimodal frequency distribution of the bonded pairs centered at 0.30 ± 
0.01 nm shows that the bonded pairs in a saccharide head group range between 0.29-0.39 nm both 
in atomistic and CG simulations. A similar frequency distribution of the average internal angles 
also shows a unimodal distribution centered at 75.2°±1.2° for all eight lipid A membranes (Figure 
3-12). These results are consistent with analysis reported earlier for P. aeruginosa CG 
parameterization.56 Although, the similarity in the bond and angle distribution is expected, the 
results demonstrate the variations in the structures and the influence that phosphorylation state and 




Figure 3-11. Average disaccharide head group bond distance frequency distribution for (A) H. 
pylori (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. 







Figure 3-12. Average disaccharide head group angle frequency distribution for (A) H. pylori (B) 
P. gingivalis, (C) B. fragilis, (D) B.pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. 
meningitides, and (H) S. Minnesota. 
For the acyl chains in all the systems, the average bond distance distribution shows unimodal curve 
centered at 0.442 ± 0.012 nm (Figure 3-13). This average bond distance is +0.142 nm larger than 
the head group bond distance because unlike the tails, head group beads are smaller and do not 
always follow the 4-to-1 mapping prescription. The acyl chain bond angle distribution is unimodal 
for all the lipid A membranes, but the location of the peak depends on the specific bacterial lipid 
A structure (Figure 3-14). For example, lipid A structures that have 17-21 carbon acyls chains (H. 
pylori, P. gingivalis, B. fragilis, and C. trachomatis) have peaks centered at 158 ± 2°, while structures 
with shorter 14-16 carbon acyl chains (C. jejuni, N. meningitidis, and S. minnesota) have peaks at 151 
± 1°, and B. pertussis with shortest 10-14 carbon acyl chains has peak at 145°. Despite having 
exactly same bond angle parameters for the acyl beads, the variation in the average angle with the 
acyl chain length as significant implication on the membrane properties. It not only demonstrates 
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that the CG parameterization is able to capture the molecular differences in these lipid A structures, 
but it also validates that the membrane properties predicted by the force field are reliable. 
 
Figure 3-13. Average acyl chain bond distance frequency distributions for (A) H. pylori, (B) P. 
gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitidis, 




Figure 3-14. Average acyl angle frequency distribution for (A) H. pylori (B) P. gingivalis, (C) B. 
fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S. 
Minnesota. 
The dihedral angles were not included for the disaccharide head group or the acyl chain beads.  
This choice was based on the earlier reports in the literature, where including of dihedral angle 
parameters required the use of an order of magnitude smaller time steps, not optimal for CG 
simulations.  Despite the absence of explicit dihedral angle parameters, the average dihedral angle 
was computed for 2 µs trajectory. In all eight membranes (Set II) the acyl chains are linear with 
average dihedral angle of 180° ± 11° or (0°± 11) through the trajectory (Figure 3-15). 
 
Figure 3-15. Dihedral angle fluctuations (degrees) as a function of simulation time for (A) H. 
pylori (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. 





3.5.2 Area per lipid (AL) and phase-transition temperature (Tm) 
In general, the AL for a lipid increases with increases in temperature as it acquires higher thermal 
energy, and if varied over a long-enough temperature range, the lipids undergo phase transition 
marked by a sharp increase in the AL versus T plot. In this work, the variation in AL for all eight 
membranes was computed over 275-360 K temperature range (Figure 3-16) to determine the phase 
transition melting temperature (Tm). To determine the Tm more precisely, the change in AL (ΔAL) 
as a function of temperature was computed as a function of T, where the peak in the curve reflects 
a sharp change in the area per lipid over a small change in temperature for an individual membrane 
(Figure 3-17).  
 
Figure 3-16. Area per lipid (AL) of Lipid A as a function of temperature for (A) Set II and (B) Set 
VII bacterial outer membrane. Color scheme: H. pylori (brown), P. gingivalis (red), B. fragilis 
(purple), B. pertussis (gray), C. trachomatis (black), C. jejuni (orange), N. meningitides (yellow), 




Figure 3-17. Phase transition temperature (Tm) for Set II membranes determined by the change in 
the AL (nm
2) versus T (K). The Tm values (K) are labeled for each curve. Color scheme for the 
lines and labels: H. pylori (brown), P. gingivalis (red), B. fragilis (purple), B. pertussis (gray), C. 
trachomatis (black), C. jejuni (orange), N. meningitides (yellow), and S. Minnesota (green). 
As with the AL values of the lipids, characteristic changes in the lipid tails were observed for the 
membranes below and above their Tm values. The tetra-acylated H. pylori lipid A has the smallest 
AL value compared to the penta-, hexa- and hepta-acylated lipid A. The AL values of the penta-
acylated lipid A (P. gingivalis, B. fragilis, C. trachomatis, and B. pertussis) are 1.2-1.3 nm2 in the 
ordered phase, below their phase transition temperature. In the disordered phase, about 10 K above 
the Tm, the AL values increase to 1.5–1.6 nm
2. Upon increasing the number of tails to six the AL 
values increase for both C. jejuni and N. meningitidis membranes. The computed AL values are in 
the range 1.45–1.48 nm2 and 1.85–1.9 nm2, 10 K below and above their Tm, respectively. The 
hepta-acylated S. minnesota, has the highest AL of 1.65 nm
2 and 2.0–2.1 nm2 10 K below and above 
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the Tm. Snapshots of the membranes below the Tm show ordered and fully extended lipid tails and 
disordered and compacted lipid tails above the Tm (Figure 3-18).  
 
Figure 3-18. Snapshots of thermal phase transition of (A) H. pylori, (B) P. gingivalis, (C) B. 
fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S. 
minnesota in Set II. The panels show ordered phase (283 K, left) and disordered phase (350 K, 
right) membrane structure. Color scheme: Lipid A head groups (orange); Lipid A acyl chains 
(cyan); DPPE head group (blue); DPPE carbon tails (magenta). 
Changing the lower leaflet composition (Set VI and VII) to include negatively charge POPG and 
cardiolipin lipid resulted in lipid A AL values that were 0.2 nm
2 larger than those in Set II. The    
slight increase in lipid A AL is a direct consequence of the presence of charge in the lower leaflet, 




3.5.3 Membrane thickness  
The DM values were computed by measuring the perpendicular distance between the planes formed 
by the phosphate head groups of the top leaflet and the bottom leaflet. As expected DM is larger at 
temperatures below Tm and smaller above the Tm. To capture this change in membrane structure, 
thickness was computed as a function of temperature for all eight membranes (Figure 3-19). All 
membranes, except B. pertussis, show ~0.51 nm decrease in DM after phase transition, which 
matches with the change in thickness observed experimentally in S. minnesota over a 30 K 
variation in temperature.26 For B. pertussis, this decrease is only about 0.24 nm because of short 
10-12 carbon acyl chains relative to others (Table 3-4). 
 
Figure 3-19. Membrane thickness (nm) as a function of T (K) for (A) H. pylori, (B) P. gingivalis, 
(C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S. 




Table 3-4 Key Properties of the Membranes and Comparison of the Phase Transition 
Temperatures from Sets II and VII with Available Experimental Data 
 
aAt T = 275 K. bReference 29. cReference 30. 
The simulated S. minnesota DM was found 4.31 and 3.93 nm 10 K below and above the Tm, which 
is in good agreement  with the electron density profile for rough mutant lipopolysaccharides Re 
(LPS Re) of S. Minnesota (strain R595). The experimentally reported upper leaflet head-group to 
lower leaflet head-group distance of the bilayer is 4.29 nm at 293 K and 3.87 nm at 323 K.  
3.5.4 Density profile 
The distribution of individual components within the lamellar asymmetrical bilayers was 
computed for all the membranes 10 K below their Tm. Because the lipids are in a thermal 
equilibrium, they adopt highly variable instantaneous molecular orientations; therefore, density 
profiles of all membrane components were calculated over 1 µs of the simulation trajectory to 
account for ensemble averaging.  
The density profiles computed for Set VI to determine the key feature of the membranes for 
comparison (Figure 3-20). At each membrane interface, the Ca2+ ions interact with the lipid 
headgroups and do not penetrate the hydrophobic tails of the outer and inner leaflets. The Ca2+ ion 
density is more pronounced in the lipid A headgroups of N. meningitidis because of the presence 
of additional phosphorylated residues that cap the phosphates at positions 1and 4’. This also 
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explains the higher density of water surrounding the lipid A headgroups than phospholipids in the 
inner leaflet. The counterion peaks in the density profile were used as a measure of the membrane 
thickness. Additionally, the density profile of C1 beads (representing the acyl chains in both 
leaflets) was plotted as a function of the membrane normal (z coordinate) as a measure of the 
hydrophobic thickness (DH). The hydrophobic thickness lies in the 2.5 −3.3 nm range depending 
on the number of carbons in the acyl chains. The C. trachomatis membrane with an average of 17 
carbons in the acyl chains has the highest hydrophobic thickness of 3.3 nm, which can be an 
important factor in determining the nature of the transmembrane porin proteins that can span the 
relatively thick outer membrane. Additionally, the high hydrophobic thickness in C. trachomatis 












   
   
  
 
Figure 3-20. Density profile of key components of (A) H. pylori, (B) P. gingivalis, (C) B. fragilis, 
(D) B. pertussis (E) C. trachomatis (F) C. jejuni, (G) N. meningitides, and (H) S. minnesota 
membranes (Set VI). Color scheme: Water (blue); Ca2+ counter ions (green); Lipid A phosphates 
(purple); DPPE head groups (red); DPPE carbon tails (black, dotted); and Lipid A carbon tails 
(orange, dotted). The Ca2+counterion density is shown on the secondary y-axis. The trough 
between the DPPE carbon tails (black, dotted) and Lipid A carbon tails (orange, dotted) profiles 




3.5.5 Radial distribution function 
The radial distribution functions (RDF) of Na+ and Ca2+ ions interacting with the negatively 
charged phosphate and carboxyl groups of lipid A were calculated for all eight membranes (Figure 
3-21). The curves for all membranes show similar trends, but notable is the peak for Ca2+-
carboxylate, which occurs at a longer distance (~1.3 nm) than the Na+-carboxylate peak (at 0.51 
nm). The peak positions imply that Na+ is able to penetrate deeper into the membrane and interact 
with carboxylate groups that lie below negatively charged phosphates.  
 
Figure 3-21. RDFs for set II (Na+, dashed) and set VI (Ca2+, solid) for phosphate (black) and 
carboxylate (red) for (A) H. pylori, (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. 
trachomatis, (F) C. jejuni, (G) N. meningitidis, and (H) S. minnesota. 
3.5.6 Diffusion coefficient 
The dynamical properties of the membrane are sensitive to the lipids that constitute the membrane 
and the physiochemical aspects of the surrounding medium. Due to the inherent complexity of the 
membranes it is often difficult to parse through these contributing factors individually. To mitigate 
the variability among the membranes, the diffusion coefficients (D) of Set I membrane systems 
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were computed, which have similar outer leaflet composition, pure DPPE inner leaflet, solvated 
in water with monovalent Na+ counterions, and at T=275 K. The data shows the S. minnesota has 
the lowest diffusion coefficient, while H. pylori has the about an order of magnitude higher 
diffusion coefficient (Table 3-4). Although there is difference in the phosphorylation state of these 
two lipids, the difference in D value is attributed primarily to the number of lipids and difference 
in molecular weight. The hexa-acylated C. jejuni and N. meningitidis have D values in same order 
of magnitude. The trend in the D values for the penta-acylated lipid A membranes (P. gingivalis, B. 
fragilis, B. pertussis, and C. trachomatis), was less apparent, but the shortest acyl chain length B. 
pertussis lipid A has the highest diffusion coefficient (Figure 3-22). As is evident from the AL and 
D data, acyl chain addition or deletion has a significant effect on the membrane properties. The 
acyl chain variability is an excellent example of a structure−property relationship showing how 
bacteria can employ this attribute to adapt to their habitats. 
 






The complexity of Gram-negative bacterial outer membranes has been a limiting factor in the 
computational modeling and characterization of these membranes. Until recently, the inherently 
asymmetric outer membranes (with LPS/phospholipid leaflets) were simplified as symmetric 
phospholipids in molecular simulations because of the lack of atomistic and coarse-grained force 
field parametrization. The development of LPS models is in its infancy, with models available for 
one or two bacterial species in atomistic and coarse-grained representations. There is therefore 
limited molecular-level understanding of the effects of the number of acyl chains, the length of 
acyl chains, and phosphorylation of a lipid on the membrane properties. The library of eight coarse-
grained bacterial lipid models studied here will provide a systematic evaluation of the factors 
contributing to the membrane properties. 
3.6.1 Effect of number of acyl chains 
Bacterial species adopt various acylation patterns to promote their survival by evading detection 
by the host innate immune system. It has been shown that penta-, tetra,- and tri-acylated lipid A 
surrogates stimulate a smaller immune response and lower cytokines levels compared to hexa-
acylated lipid A. Some bacteria actively modify lipid A in response to changes in temperature of 
the host. An example is Yersinia pestis that produces hexa-acylated lipid A under ambient 
conditions but shifts to a tetra-acylated form at temperatures close to mammalian body 
temperature. In other cases, such as S. typhimurium and P. aeruginosa, acylation patterns are 
modified by enzyme activity in response to hostile chemical stimuli, such as depletion of cationic 
counterions, changes in pH, and presence of antimicrobial peptides, among others. The variability 
in acyl chains permits up and down regulation of outer membrane permeability and structural 
integrity, thus enhancing bacterial survival in harsh non-optimal environments. 
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The eight bacterial lipids studied here represent a range in lipid A structural diversity with 4–7 
acyl chains. Analyzing the AL data (Table 3-4) 10 K below the phase transition (Tm −10 K) shows 
that on an average each lipid tail contributes to ~0.24 nm2 to the area occupied by a lipid molecule. 
While this rule-of-thumb holds well for the membranes below their phase transition temperature, 
the contribution of the lipid tails increases to ~0.31 nm2 above the Tm in the disordered phase. 
Additionally, increasing the number of chains decreases the diffusivity of the lipid. Diffusion 
coefficient data from simulations of the eight lipid, under similar physiochemical conditions show 
that hepta-acylated lipid A is an order of magnitude lower than the tetra-acylated surrogate, and 
values of hexa- and penta-acylated lipid A are range between the two extremes (Figure 3-22).   
3.6.2 Effect of acyl chain length 
Membrane microstructure is dependent on the lipid-lipid interactions between adjacent molecules 
and is intimately tied to the length of the acyl chains and the average hydrophobic thickness. A 
membrane with a larger hydrophobic thickness experiences increased van der Waals attractions 
between neighboring lipids, resulting in lower area per lipid and a higher phase transition 
temperature. The data from the eight membranes studied here reflect the expected trend. Pair wise 
comparisons of B. pertussis and C. trachomatis membranes, which have the shortest and longest 
acyl chains of the group, show that C. trachomatis (with at least 2–6 additional carbons in the acyl 
chains) has a higher hydrophobic thickness (∆DH = +0.6 nm), lower area per lipid (∆AL = −0.07 
nm2), and a higher phase transition temperature (∆Tm = + 27 K) than does B. pertussis. Density 
profiles of the membranes (Figure 3-23) show that the difference in the total membrane thickness 
(∆DM = +0.6 nm) arises due to the hydrophobic thickness alone and not due to the disaccharide 
head groups. In addition, comparing density profiles (Figure 3-20) of P. gingivalis and B. fragilis 
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membranes, which have similar lipid A structures in terms of number of acyl chains, 
phosphorylation, but differ only by one carbon in two of its acyl chain, have similar values for AL, 
DM, DH, and Tm (Table 3-4).  
 
Figure 3-23. Density profiles of key components of (A) B. pertussis and (B) C. trachomatis 
membranes (set VI). Color scheme: water (blue); lipid A phosphates (purple); DPPE headgroups 
(red); inner leaflet carbon tails (black, dotted); outer leaflet carbon tails (orange, dotted). The 
Ca2+ counterion density (green) is shown on the secondary y-axis. 
3.6.3 Effect of phosphorylation and counterions 
The phosphorylation state of the disaccharide head group influences lipid A-mediated 
endotoxicity. Bacteria species with missing phosphates are resistant to antimicrobial peptides and 
are less active than the diphosphorylated lipids. For example, H. pylori consists of a tetra-acylated 
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lipid A that lacks the 4ʹ-phosphate group to evade detection by Toll-like receptor 4 (TLR4) and 
resists action by antimicrobial peptides.27 In Salmonella typhimurium, neutralizing the phosphates 
results in increased antimicrobial resistance and decreased immunogenic response.28 
Furthermore, the negatively charged phosphates act as coordination sites for divalent ions to 
chelate adjacent LPS molecules. Comparison of phosphate-Ca2+ radial distribution functions, 
2+P-Ca
( )g r in H. pylori, C jejuni, and N. meningitidis, all show a predominant peak at 0.5nm,r =
irrespective of the number of phosphates on lipid A head groups (Figure 3-24). The separation 
distance of 0.5 nm is particularly important because it is the signature of the closest non-bonded 
distance between two CG beads. Unlike 2+P-Ca
( ),g r phosphate-phosphate (P-P) radial distribution 
functions P-P ( )g r clearly show differences in the phosphorylation states among these lipid A 
structures. H. pylori with one phosphate (at position 1 of the disaccharide head group) shows a low 
intensity P-P peak at 0.5 nm, mediated by the Ca2+ ions, but majority of the phosphates are less 
organized illustrated by the broader peak centered at 0.8 nm (Figure 3-24A). On the other hand, 
C. jejuni with two phosphate groups (at positions 1 and 4') shows well-defined peaks at 0.6 and 
0.9 nm that correspond to the head-on intermolecular and the intramolecular P-P interactions, 
respectively (Figure 3-24B). Finally, N. meningitidis with four phosphates (bonded pair at 
positions 1 and 4') shows a bonded P-P peak at 0.3 nm, and broader peak centered at 0.9 nm. The 
differences in the ionic charge density at the lipid A-water interface is shown in the inset snapshots 
in Figure 3-24. As expected H. pylori snapshot shows lowest charge density, which is considered 






Figure 3-24. Lipid A headgroup phosphate −phosphate (gP −P(r); solid lines) and phosphate −Ca
2+ 
counterion (gP −Ca
2+(r); dashed lines) radial distribution functions for (A) H. pylori, (B) C. 
jejuni, and (C) N. meningitidis. The inset images show top views of the lipid A headgroup 



















This work provides thermodynamic and dynamical properties of a diverse set of eight bacterial 
membranes commensal or human pathogenic Gram-negative bacteria species: Helicobacter pylori, 
Porphyromonas gingivalis, Bacteroides fragilis, Bordetella pertussis, Chlamydia trachomatis, 
Campylobacter jejuni, Neisseria meningitidis, and Salmonella minnesota. This representative set 
of Gram-negative bacteria have lipid A domains that differ in the degree of phosphorylation 
presence of phosphate substituents, glucosamine head group as well as the nature, number, 
location, and length of acyl chains. After multiple independent simulations for all membranes, 
several key characteristics emerge. First, we find that on an average each lipid tail contributes 
~0.24 nm2 to the total area of the lipid, therefore AL values of hepta-acylated S minneosta and tetra-
acylated H. pylori lipid A are in 7:4 ratio. Second, the membranes composed of longer acyl chain 
lipid A have smaller AL and a higher phase transition temperature compared to their shorter acyl 
chain counterparts. Third, membrane composition and charge of the inner leaflet can influence the 
phase transition temperature of the membrane by 20-30 K. Four, the monovalent ions bury 
themselves deeper in the membrane headgroups whereas the divalent ions are superficial and act 
as chelating agents binding to the phosphates on adjacent lipid A molecules. The insights from the 
work presented here coupled with the development of library of lipid A coarse-grained topology 
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Dynamics of OmpF trimer formation in the bacterial outer 
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The self-assembly of outer membrane protein F (OmpF) in the outer membrane of Escherichia 
coli Gram-negative bacteria was studied using multiscale molecular dynamics simulations. To 
accommodate the long timescale required for protein assembly, coarse-grained parameterization 
of E. coli outer membrane lipids was first developed. The OmpF monomers formed stable dimers 
at specific protein-protein interactions sites, exactly as identified in earlier literature. The dimer 
intermediate was asymmetric but provided a template to form a symmetric trimer. Superposition 
analysis of the self-assembled trimer with the X-ray crystal structure of the trimer available in the 
protein data bank showed excellent agreement with global root-mean square deviation of less than 
2.2 Å. The free energy change associated with dimer formation was −26±1 kcal mol−1, and for a 
dimer to bind to a monomer and to form a trimer yielded −56±4 kcal mol−1. Based on 
thermodynamic data, an alternate path to trimer formation via interaction of two dimers is also 











4.2 INTRODUCTION  
Porins are barrel-shaped membrane proteins in the Gram-negative bacterial outer membrane; these 
hydrophilic nanochannels permit the diffusion-mediated influx of nutrients through the otherwise 
impermeable outer membrane.1-4 Porins are classified as non-specific channels because their low 
affinity to bind to substrates results in the gradient-based diffusion of small substrates into the 
bacterial cell. In contrast, specific protein channels are restrictive and have binding sites for 
particular chemical substrates to facilitate selective transport. A typical Gram-negative bacterial 
species may express several outer membrane channel proteins that differ structurally (lumen 
diameter, number of strands, and oligomeric state) and channel functionally (specific or non-
specific).  
In the bacterial outer membrane, porins encounter an asymmetric lipid environment with 
lipopolysaccharide (LPS) in the outer leaflet and a mixture of phospholipids in the inner leaflet.5 
The LPS is a complex molecule that is composed of three domains—Lipid A, the core 
oligosaccharide, and the O-antigen.6 Lipid A domain forms stabilizing non-bonded interactions 
with the exposed hydrophobic residues on the porin surface. The four to seven saturated fatty acid 
chains of Lipid A facilitate the tight packing of LPS molecules with protein channels to maintain 
the outer membrane’s impermeability to hydrophobic substrates. The negatively charged core 
oligosaccharide domain is cross-linked via divalent counterions to enhance outer membrane 
stability and impermeability.7 The O-antigen consists of many repeats of an oligosaccharide unit 
that extend outwards from the membrane into the bacterial surroundings.  
In Escherichia coli, nutrient uptake is mediated by the non-specific outer membrane protein F 
(OmpF), which consists of a homotrimeric β-barrel assembly.3,8 Each monomer has a cylindrical 
topology formed by a 16-stranded peptide backbone arranged in an antiparallel motif. Its 
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hydrophobic side-chain residues are exposed to membrane lipids, while the hydrophilic residues 
form the lumen of the channel. The β-strands are connected via short turns (T1−T8) on the 
intracellular side of the channel and longer loops (L1−L8) on the extracellular side. Loops interact 
with LPS core domain to provide stability.9-12 In addition, L2 of each monomer participates in 
stabilizing non-covalent interactions with the adjoining monomers within the trimeric assembly, 
while the L3 buries into the lumen of the barrel to form a size-selective constriction zone for the 
channel.13 The E. coli OmpF constriction zone is marked by positively and negatively charged 
residues on opposing sides of the lumen, which are important for diffusion of charged substrates. 
The high-resolution X-ray crystal structures of OmpF provide atomistic-level resolution of the 
trimer,8 but these static structures lack the mechanistic and dynamic details governing 
trimerization. Molecular dynamics (MD) simulations enable the extrapolation of static structures 
to physiological events that can then be compared to experimental results. In previous molecular 
dynamics (MD) simulations, the influence of the variability of the LPS environments on the 
structure and dynamics of OmpF trimer was reported using all-atom MD simulations.14,15  Studies 
of trimeric OmpF revealed deviations of dynamical structure relative to the crystal structure and 
showed that L3 flexibility affected a change in pore cavity. Molecular dynamics simulations were 
also successfully used to observe solute behavior and passage through OmpF, and findings 
compared to experimental results.12,13 The recent development of new algorithms has enabled 
research to simulate ion conduction directly using applied field MD simulations.16,17  
Dimeric and monomeric states of OmpF also have been observed in vivo and in vitro 
experiments.18-22 These findings suggest that the mechanism of OmpF formation proceeds in a 
stepwise manner from monomers to dimers to trimers. In a computational study involving 
dynamics of OmpF monomers in asymmetric phospholipid bilayers showed clustering and reduced 
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mobility of the OmpFs in a crowded lipid environments,23 but did not specifically focus on the 
mechanism of OmpF trimer formation. Other studies focused on the formation of OmpF assembly 
revealed that the oligomerization occurs via specific protein-protein pair interactions.24-26  Each 
OmpF monomer has two distinct patches centered at residues Glycine-19 (G19) and Glycine-135 
(G135) that participate in oligomerization. A dimer is formed when G19 of an OmpF monomer 
interfaces with G135ʹ patch of the OmpFʹ monomer. This dimer then interacts with the third 
OmpFʺ monomer at the exposed G135 and G19ʹ patches to form G135-G19ʺ and G19ʹ-G135ʺ 
interfaces to complete the OmpF-OmpFʹ-OmpFʺ trimer. Mutagenesis experiments have revealed 
that perturbing these interfacial residues results in loss of oligomerization.24 In addition to 
thermodynamic stability, oligomerization of OmpF provides structural support for the extracellular 
loops. Niramitranon et al. showed that the OmpF trimer functions as a non-specific pore, but as a 
monomer it becomes anion-selective due to the dislocation of the D113 side chain on L3 loop, 
which blocks the cation pathway.15 Other research indicates that the change of the location of side 
chains, the helices, or even the quaternary structure will result in porin malfunction.27 The self-
assembly simulation results in conjunction to previous literature indicates that being a trimer in 
E.coli’s outer membrane significantly decreases the structural flexibility of the OmpF and aids in 
maintaining the pore function by allowing exchange of both cations and anions, which is essential 
for E.coli survival.15 Several reports of computational studies involving the stability and 
interactions of other trimeric bacterial porins based on from their trimeric X-ray crystallographic 
structure.10-12,14-15,28-30 However, the stepwise assembly and molecular origins of OmpF 
trimerization have not yet been studied in detail due to the inability to perform long-time scale 
simulations with high fidelity to the underlying molecular structure. 
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Here we report the development of a coarse-grain force field parameter set for E. coil outer 
membrane lipids, which includes the Lipid A (LPA) and Lipid A with core (LPC). The force field 
parameters are similar in spirit to the recently reported coarse-grained parameter sets for bacterial 
lipids30-32 that reduce the degrees of freedom of the system and provides a computationally 
affordable route to explore dynamics of molecular assemblies in microsecond timescales.33-40 
Using the developed parameter set, we computed structural properties of LPA and LPC lipid 
membranes, such as area per lipid, phase transition temperature, density profiles, hydrophobic 
thickness, bond distances and bond angles analysis, and compared our findings to available 
experimental and atomistic simulation results.  
The outer membrane formed by the combination of the LPA in the outer leaflet and phospholipids 
in the inner leaflet was used to study the oligomerization process of OmpF monomers to more 
complex structures over tens of microseconds. We demonstrate the stepwise assembly of 
monomeric OmpF into a stable dimer and subsequent interaction with another monomer to form a 
stable trimer. The formation of OmpF trimer is a multibody interaction involving numerous 
protein-protein and protein-lipid binding and unbinding events. In general, protein self-assembly 
is a complex interplay of long-range (electrostatics, diffusivity, viscosity) and short-range 
(hydrogen bonding, hydrophobic and hydrophilic interactions, and van der Waal interactions) 









The E. coli lipid A head group (Figure 4-1) is a β(1→6)-linked D-glucosamine disaccharide linked 
to C14 acyl carbon chains at positions 2 and 3 as well as 2′ and 3′ via amide or ester linkages.
41 
The glucosamine residues (GlcN I and II) of the disaccharide head group are phosphorylated at 
positions 1 and 4′. Nonhydroxy saturated C12 and C14 secondary carbon chains further esterify 
the primary acyl chains at positions 2′ and 3′. The primary hydroxyl at position 6′ acts as the 
binding site of the core LPS oligosaccharide domain. The core oligosaccharide domain is branched 
and contains six to 10 hexoses (glucose and galactose units) with multiple anionic groups.6 The 
divalent counterions act as chelating agents for the core anionic groups, diminish the electrostatic 
repulsion between neighboring LPS molecules, and provide stability to the membrane.116 The 
outermost O-antigen domain is also an oligosaccharide consisting of 1−40 repeat units that extend 
into the surrounding medium.31,43 Overall, there is high variability in the length of core and O-
antigen oligosaccharides in E. coli; however, only lipid A and partial core oligosaccharides are 




Figure 4-1. The chemical structure of E. coli lipid A domain. The head group is a β(1→6)-linked 
D-glucosamine disaccharide linked to C14 acyl carbon chains at positions 2 and 3 as well as 2′ 
and 3′ via amide or ester linkages. The glucosamine residues (GlcN I and II) of the disaccharide 
head group are phosphorylated at positions 1 and 4′. Nonhydroxy saturated C12 and C14 
secondary carbon chains further esterify the primary acyl chains at positions 2′ and 3′. The 
primary hydroxyl at position 6′ acts as the binding site of the core LPS oligosaccharide domain. 
 
Here we develop the parameter set for lipid A and oligosaccharide core in the outer membrane of 
E. coli (Tables S1−S4) using the coarse-graining approach reported previously.36,38 The coarse-
grain parameterization of lipid A was developed based on MARTINI many-to-one mapping in 
which on average four or three heavy atoms are mapped into one bead (Figure 4-2).44-46 Using the 
Lipid A template reported earlier,36,38 each glucosamine unit was assigned four beads (P1, P2, P4, 
P5) and each phosphate was mapped into one Qa bead type with a unit negative charge (Figure 4-
3). The acyl chain beads were assigned C1 bead type. The frequency distribution of the average 
bond lengths and angles of the acyl chains and glucose residues were computed (Figure 4-4 and 
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4-5). Sodium and calcium ions were used as counter ions to make the whole system electrically 
neutral. The E. coli parameter set adds to our library of nine bacterial species: Pseudomonas 
aeruginosa, Helicobacter pylori, Porphyromonas gingivalis, Bacteroides fragilis, Bordetella 
pertussis, Chlamydia trachomatis, Campylobacter jejuni, Neisseria meningitidis, and Salmonella 
minnesota.  
 
Figure 4-2. Representative chemical structure of E.coli (a) LPA, (b) LPC and (c) coarse grain 
mapping of LPC. Panels (a) and (b) shows LPA and LPC phosphates (peach) and caroxylate 
(orange; triangle) anionic groups, residue SYB and XYA (yellow; 3-(acetyl amino)-3-deoxy-D-
glucose), LP1 (gray; 2-hydroxytetradecanoyl acid), LP2 (gray; dodecanoyl acid decyl ester) and 
LP3 (gray; tetracanoyl acid decyl ester), and residues GAL (magenta; D-galactose), GLC 
(magenta; D-glucose) and HEP(magenta; L-glycero-D-manno heptose), LKO and 0KO (gray; 3-





Figure 4-3. (A) PO4, (B) XYA, (C) SYB, (D) LKO, (E) 0KO, (F) Gal 1, (G) Gal 2, (H) Glc1, (I) 
Glc 2, (J) Hep 1,(K) Hep 2,(L) Hep 3,(M) LP1,(N) LP2, (O) LP3. The coarse grained mapping 
scheme showing Martini beads of types Qa (black), P1 (yellow), P2 (blue), P4 (orange), P5 
(green), N0 (purple), Na (light blue), and C1(grey) and overlaid on the atomistic structure in ball 



























Figure 4-4. (A) Average acyl bond and B) angle frequency distribution. Average disaccharide 




















































































Figure 4-5. Dihedral angle fluctuations (degrees) as a function of simulation time. 
 
4.3.2 Simulation details 
Asymmetric Membranes: We investigated three model membranes with varying level of lipid 
complexity to capture the asymmetric behavior of E. coli membrane and the dynamics of OmpF 
trimer self-assembly. The first membrane type (MT1) comprises of a Lipid A (LPA) in the outer 
leaflet and DPPE in the inner leaflet. The second membrane type (MT2) is a combination of Lipid 
A plus core (LPC) in the outer leaflet and DPPE in the inner leaflet. The third membrane type 
(MT3) comprises of LPA:DPPE (9:1) outer leaflet, and a ratio 7:2:1 mixture of 1-hexadecanoyl-
2-(9Z-octadecenoyl)-sn-glycero-3 phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG), and cardiolipin (CDL2) in the inner leaflet, which most 
closely mimics to the composition of the E. coli membrane. The outer leaflet LPA:DPPE lipid 
ratio was maintained at 9:1 to the mimic the small concentrations of phospholipids that get 
recruited from the lower leaflet to stabilize the membrane under stress.47  
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The initial configuration of a coarse-grained membrane patches (10×10 nm2) were for built using 
a locally modified version of python script called insane.py.48 The script uses a built-in library of 
lipids, ions and solvents to generate systems of the MT1−MT3 lipid membrane (Table 4-1). The 
E. coli LPA and LPC lipid templates were added, and the latest local version of the script is 
available to researchers. The membranes were solvated with standard MARTINI water, and the 
electroneutrality of the system was maintained using hydrated Na+ or Ca2+ counterions.  




Outer leaftet  Inner leaftet Counter 
Ion 
No. of 
T (K) t (𝜇s) 
LPA LPC DPPE  DPPE  POPG CDL2 water ions 
MT1a 77 - -  231 - - Na+ 4358 154 323 2 
MT1b 77 - -  231 - - Na+ 4358 154 295-360 2 
MT2a - 81 -  243 - - Na+ 5831 486 323 2 
MT2b - 81 -  243 - - Na+ 5831 486 295-411 2 
MT3a 69 - 7  137 39 19 Ca2+ 4607 107 310 2 
MT3b 69 - 7  137 39 19 Ca2+ 4607 107 260-345 2 
aSimulations to determine equilibrium properties of the membrane 
bSimulations to determine the phase transition temperarure 
 
Membrane Protein Systems: The coarse-grained form of monomeric OmpF (pdb:4LSF) was 
downloaded from the online MemprotMD server,49 which is an online repository for obtaining 
equilibrated protein structures in coarse-grained representation. The modified insane script was 
then used to insert the coarse-grained OmpF monomers in the desired membrane type (Table 4-2), 
as well as add water and counterions. The monomers were placed in a square grid (2×2 or 3×3), 
equidistant from each other and in random orientations (Figure 4-6a) to remove any 
conformational bias during self-assembly. Simulations were performed in two stages, where the 
OmpF monomers were initially position-restrained for 0.5 µs to equilibrate the surrounding lipids, 




Table 4-2. System details of OmpF-membrane simulations. 
aSimulation time for each umbrella sampling window 
 
 
Figure 4-6. Simulation setup and self-assembly of OmpF trimer. (a) Side and top-view of a 3×3 
grid of coarse-grained OmpF monomers (cyan, surface representation) in E. coli outer membrane 
MT3  (System 3) comprised of LPA (yellow and white beads) outer leaflet  and a complex inner 
leaflet of DPPE (orange beads), POPG (blue beads), and CDL2 (magenta beads).  Snaphots (top 
view) of (b) stable dimer (System 1), (c) dimer (System 3), (d) fleeting dimer interaction (System 
2), and (e) formation of OmpF trimer (System 6). In panels (b−e), the position of G19 (red bead) 
and G135 (yellow bead) residues is highglighed; other components of the system are not shown 
for clarity. 
System MT 
Outer leaftet  Inner leaftet  Protein  No. of  T 
(K) 
t 
(𝜇s) LPA LPC DPPE  DPPE POPG CDL2  OmpF  water ions  
1 MT1 124 - 12  384 - -  4  31376 296  310 48 
2 MT3 124 - 12  244 68 36  4  19663 436  325 40 
3 MT3 81 - 9  162 45 18  9  13842 351  325 24 
4 MT2 - 72 8  224 - -  4  15629 480  310 48 
5 MT2 - 81 9  252 - -  9  15777 297  310 20 
6 MT3 207 - 22  410 117 58  3  34520 683  325 16 
7 MT2 - 225 25  445 129 63  3  23049 1641  310 2 
8 MT1 234 - 26  728 - -  2  25570 246  310 0.5a 
     9 MT1 216 - 24  672 - -  3  26370 234  310 0.5a 
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Simulation set-up: The GROMACS molecular dynamics package50,51 (5.1.2) was used to perform 
all simulations. Energy minimization was performed using the steepest-decent algorithm with a 20 
fs time-step until the maximum force on any bead was below the tolerance parameter of 10 
kJmol−1nm−1. Periodic boundary conditions were applied in all three dimensions. The NVT 
(constant number of particles, volume, and temperature) and NPT (constant number of particles, 
pressure, and temperature) equilibration runs were performed for 0.2 µs. Semi-isotropic pressure 
coupling was used, and systems were maintained at 1 bar using the Berendsen barostat27 with time 
constant, τp = 4.0 ps. Temperature was maintained at 310 or 325 K by independently coupling the 
lipids, proteins, and the solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The 
neighbor list was updated every 25 steps using 1.4 and 1.2 nm for short-range van der Waals and 
electrostatic cutoffs, respectively. The production NPT simulations were performed for 2 µs for 
the membrane without proteins (Table 4-1) and between 2−48 µs for membranes with embedded 
OmpF proteins (Table 4-2). For membranes without proteins, annealing simulations were 
performed to obtain the phase transition temperatures; in brief, a short NPT was performed at 275 
K followed by a heating scan from 275−360 K with a 15 K interval.  
Potential of Mean Force (PMF) Calculations: To compute the PMF curves, we extracted the 
self-assembled dimer and trimer from the equilibrium simulations (Systems 3 and 6, respectively) 
and embedded them independently in 30×10 nm2 membrane patches of simple MT1 bilayer; 
system 8 and 9, respectively. The MT1 lipids were equilibrated while keeping the proteins 
position-restrained for 0.5 µs at 310 K. The restraints were then removed and pull simulations were 
performed along the reaction coordinate defined by separation of the center of mass (COM) of the 
interacting OmpFs while still embedded in MT1 bilayer. In case of both the dimer and the trimer, 
one OmpF was pulled with respect to the COM of its position-restrained oligomeric counterpart. 
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A harmonic potential with 1000 kJmol-1 nm2 force constant was used for the pull. A total of 30-40 
independent umbrella sampling windows were extracted along the reaction coordinate for both 
systems, and each window was simulated for 0.5 s. The weighted histogram analysis method 
(WHAM) along with bootstrapping was used to extract the PMF curves. 
General Analysis: Post simulation analyses were performed using in-built GROMACS utilities, 
and external software suites such as YASARA52 for protein alignment with X-ray crystal structure 
and CAVER41 for analysis and visualization of porin channels. The use of YASARA and CAVER 
required reverse mapping of the OmpF from the CG representation to atomistic, which was 
achieved by using backward.py script that uses a library of mapping definitions to reconstruct the 
all-atom representation. Structural properties of the membranes such as area per lipid (AL), phase 
transition temperature (Tm), membrane thickness (DM), and hydrophobic thickness (DH) were 
computed.  Molecular visualization and graphics were generated using VMD43 and YASARA.52  
4.4 RESULTS AND DISCUSSION  
4.4.1 Force field development and validation of membrane properties 
Parameterization of E. coli outer membrane lipids is essential for examining OmpF assembly 
because the protein-protein interactions occur in the membrane milieu. Unlike most biological 
membranes that are symmetric, the asymmetric outer membrane comprising LPS-rich outer 
leaflets and phospholipid-rich inner leaflets characteristic of Gram-negative bacteria contribute to 
the membrane’s striking properties. The presence of LPS in the outer leaflet provides a highly 
negatively charged hydrophilic nature to the bacterial membrane. Given that the complex outer 
membrane environment influences the in vivo OmpF assembly, the E. coli LPS force field 
parameter set should be accurately benchmarked before the in silico characterization of OmpF 
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assembly. A well-parameterized membrane force field should provide agreement with the 
available experimental data within the statistical uncertainty in the measurement.  
4.4.1.1 Area per lipid 
The AL quantifies the two-dimensional density of a membrane and captures the membrane phase 
behavior.29,30 The correct prediction of AL value enables us to assess the quality of the 
parameterization of the force field because the AL value is sensitive to molecular-level interactions 
(lipid-lipid and lipid-water interface). The AL is a highly averaged equilibrium property of a 
membrane and is often computationally expensive to calculate in an atomistic simulation due to 
slow diffusion of lipids in a bilayer.23 Thus, a simplistic approach to compute AL is to divide the 
cross-sectional area of the equilibrated membrane by the total number of lipids in each leaflet. 
Using the CG parameter set developed here, we were able to equilibrate the E.coli outer membrane 
and compute AL. 
The AL values for MT1 and MT2 at 323 K after 2 s of equilibration are 1.39±0.02 and 1.53±0.06 
nm2, respectively (Figure 4-7A). These values compare well to published AL values of 1.38−1.56 
nm2 (Table 4-3).14,42,53 Given that AL is a function of membrane composition and temperature, it is 
not surprising that there is a 0.18 nm2 variation in experimentally observed AL values. The AL for 
LPC-rich MT2 should be higher than MT1 because the charged core oligosaccharide domain has 
four additional negative charges per lipid A leading to higher electrostatic repulsion and larger 
lipid-lipid separation, whereas in the LPA-rich MT1, the lipid tails predominantly interact via van 
der Waals forces. Wu et al. using atomistic simulations also showed that AL increases with the 
addition of core domain.14 The AL values for MT3 at 310 K after 2 s of equilibration is 1.86±0.06 
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nm2; this value is higher than MT1 and MT2 (Table 4-3) because the heterogenity of the mixture 



















Figure 4-7. (A) AL of outer leaflet lipids in MT1 (orange), MT2 (cyan), and MT3 (green) 
membranes in (B) Effect of temperature on AL of outer membrane (same color scheme). (C)  









Table 4-3 Comparison of area per lipid of lipopolysachharides, phase transition temperature and 
membrane thickness, and hydrophobic thickness data of MT1, MT2, and MT3 models with 
available data in the literature.  
Properties 
MT1a,b  MT2 a,b 
 
MT3 a,b 









Tm (K) 319±2 317.5/314.15  328±1 -  285±3  









aSimulations to determine equilibrium properties AL,DM, and DH 
bAnnealing simulations to determine Tm 
 
4.4.1.2 Phase transition temperature  
The bacterial outer membrane can be in a gel (ordered) or liquid (disordered) phase depending 
upon whether it’s characteristic phase transition temperature (Tm) is lower or higher than ambient 
temperature. The phase transition is a rapid physical change in the membrane’s properties as a 
function of temperature; it depends on multiple factors such as membrane composition, charge per 
lipid, length and number of acyl chains, degree of unsaturation in lipid chains, and branching in 
core domain. Each bacterial species has a characteristic Tm.
38 Bacterial species are often able to 
manipulate the makeup of their membrane lipids to adapt to the surrounding temperature for 
survival.32,41  
For an equilibrated membrane, the AL for a lipid increases with increases in temperature; therefore, 
AL of a disordered liquid phase membrane is significantly larger than in gel phase due to the weaker 
interactions between lipid A chains. The change in AL is gradual with temperature until Tm is 
achieved, where gel-liquid phase change occurs. Once the temperature is above the Tm, a rapid 
increase of AL occurs due to the phase change, which is captured from the change in the slope of 
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AL versus T plot (Figure 4-7B). The three model membranes (MT1-MT3), have Tm ranging from 
285 to 328 K based on the composition of outer and inner leaflets (Table 4-3). These results are 
consistent with our earlier work, where Tm of LPA−complex or MT3 membrane of N. meningitidis 
(hexacyl Lipid A) was lower (284±2) compared to LPA−DPPE or MT1 (324±3 K).38 The Tm of E. 
coli LPS-DPPE membrane was observed to be 317.15 K in atomistic simulations.53 Naumann et 
al. estimated Tm to be 314.15 K via Fourier-transform infrared spectroscopy.
54 However, limited 
data were reported about the Tm of complete outer membrane of E. coli with core oligosaccharide. 
4.4.1.3 Other structural properties  
Density profile of water, lipid tails, phosphate, and counter ions in MT1-MT3 systems were 
computed (Figure 4-8) to examine the effect of LPA and LPC in the outer leaflet, and the influence 
of a mixture of lipids in the lower leaflet. MT2 shows penetration of counter ions into the outer 
LPC leaflet to interact with the core oligosaccharide phosphates. The difference between the 
phosphate peaks of the outer and inner leaflets of the membrane was used to calculate the 
membrane thickness of the membrane, which is 4.28±0.11 and 3.92±0.09 nm for MT1 and MT3, 
respectively.  
The MT2 membrane with the additional core domain in the outer leaflet lipids is considerably 
thicker (6.11±0.18 nm) than the both MT1 and MT3, as expected. In comparison to the 
Pseudomonas aeruginosa LPC-DPPE membrane type the membrane thickness value lies within 
the previously reported 6.1-6.6 nm range.36 The density profile of water showed that the 
membranes are impermeable to water as the density of water decreases to zero close to the 
membrane mid-plane between 4-6 nm, although water can penetrate the core domain of LPA and 




Figure 4-8. Density profile of (a) MT1, (b) MT2 and (c) MT3. Color scheme: LPA (orange line) 
and LPC (gray line); DPPE (red line); POPG (light red line); CDL2 (pink line); phosphates (green 
line); ions (black line); water (blue line); inner DPPE leaflet (dark gray, shaded area) and outer 
leaflet (light gray shaded area). The inset cartoon images of lipids in the shaded areas are provided 
as a guide.  
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The hydrophobic thickness of MT1 and MT2 bilayers was calculated from the density profile of 
the acyl chains (Figure 4-7C). The MT1 bilayer, having only the lipid A domain in the outer leaflet, 
has a larger (2.9 nm) hydrophobic thickness compared to the MT2 bilayer (2.5 nm) with the 
additional core domain linked to lipid A. This observation demonstrates the inverse correlation of 
the hydrophobic thickness with the AL, because higher area per lipid leads to smaller hydrophobic 
thickness, as reported previously.14 
4.4.2 OmpF self-assembly simulations 
4.4.2.1 Dimer and trimer formation 
The dynamics of OmpF assembly in the outer membrane revealed a two-step process involving 
formation of an intermediate dimer that leads to the formation of a trimer. Several events involving 
OmpF binding and unbinding were observed (Figure 4-6) as the proteins diffused through the MT1 
and MT3 bilayers. The interactions in which monomers aggregated via the G19-G135 protein-
protein interface resulted in stable dimers (Figure 4-6b and 4-6c).The lifetime of the OmpF dimer 
was dependent on the stability of the G19-G135 protein-protein interface. In most instances 
monomers OmpF and OmpF' had fleeting interactions and did not lead to stable dimers (Figure 4-
6d). Note that the superscript on OmpFʹ has been used to differentiate the two monomers only for 
the clarity of the present discussion. To track formation of stable dimers, we computed the G19-
G135 separation distances for all interacting OmpF and OmpF' pairs. System 1, 2, and 3 formed 
stable dimers and achieved an average minimum G19-G135 separation distance of 2.05 ± 0.05 
(Figure 4-9).  Other OmpF-OmpF' dimer interactions in which association did not occur via G19-
G135 interfaces, the G19-G135 pair separation remained larger than 2.05 ± 0.05 nm (Figure 4-9) 
during the entire trajectory, and dimer association was short-lived (Figure 4-6d). In a series of 
studies involving OmpF oligomerization, the G19 and G135 patches were identified as weakly 
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stable regions of the OmpF β-barrel that interface with another monomer to acquire stability. 
Naveed et al. showed that site-directed mutagenesis of G19 with energetically unfavorable 
residues resulted in OmpF mutants with only monomers.24 Although simulations of the self-
assembly of mutated OmpF are beyond the scope of the present work, the observed G19-G135 
dimer is consistent with these previously reported results.  
 
Figure 4-9. Distances between interfacial G19 and G135 residues in Fig.4-6b (purple), Fig.4-6c 
(green) and Fig. 4-6d (blue).  
 
Analysis of the number density plots of equilibrated lipids in system 3, showed a high density 
corona of LPA molecules around the OmpF monomers (Figure 4-10a). The presence of LPA, 
however, did not prevent the oligomerization or arrest diffusion of OmpF in the membrane (Figure 
4b−d). The plots exhibit asymmetry in the localization of upper and lower leaflet lipids and their 
adaptation to the OmpFs. The negatively charged head groups of LPA interact with the charged 
loop regions of the OmpFs, but do not appear to stabilize the weakly stable G19 and G135 patches, 
because in cases where a stable dimer is formed, the interacting OmpF interface gradually 
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delipidates (Figure 4-10a). The lower leaflet DPPE molecules do not form a corona around the 
OmpF monomer at the beginning of the simulation or after the dimer is formed (Figure 4-10b). 
Similarly, the negatively charged POPG and CDL2 also do not form a high density corona, which 
may be due to their low concentration in compared to DPPE in the lower leaflet (Figure 4-10 c−d). 
The counterions interact with the charged loop domains and form hot spots at the dimer interface 
due to localization of the OmpF loops.   
 
Figure 4-10. Average partial number density of membrane components (a) LPA (outer leaflet), 
(b) DPPE (inner leaflet), (c) POPG (inner leaflet), (d) CDL2 (inner leaflet), and (e) ions 
(membrane surface) during two microsecond intervals of trimer formation (System 3). 
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Structural analysis of the assembled dimer in System 3 shows lack of symmetry (Figure 4-11a). In 
addition to the obvious asymmetry caused by the G19-G135 interface, the OmpF and OmpF' 
channel lumens also have different diameters in the bottleneck region of 0.71 and 0.84 nm, 
respectively. The overall root-mean-square deviations (RMSD) of individual monomers are also 
different; the wider lumen monomer has higher flexibility (Figure 4-11b). Evidence of asymmetric 
conductance through the dimeric pore has been reported previously.22 The asymmetry was 
observed in all dimers, including those formed in Systems 1 and 2.  
 
Figure 4-11. Reversed mapped snapshot of the self-assembled OmpF-OmpF' dimer (cyan; 
surface representation) in System 3. Difference in (a) pore lumens (arrows) and (b) the overall 
root-mean-square deviation of individual OmpF (orange) and OmpF' (black) units in the dimer as 
a function of time. The G19 (red) and G135 (yellow) residues are shown as beads. 
 
Furthermore, the asymmetric orientation of the dimer leaves two exposed patches, G135 on OmpF 
and the G19 on OmpF', which together can accommodate a third OmpF chain to yield a trimer. 
Simulation results show trimer formation after 16 µs (Figure 4-6e), where the OmpF-OmpF' dimer 
gradually orients to interface with the OmpFʺ monomer to form the trimer (OmpF-OmpFʹ-OmpFʺ) 
with C3 symmetry. The number density profile of the membrane lipids involved in trimer 
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formation (System 6) shows a thin LPA corona around the OmpFs throughout the assembly 
(Figure 4-12a). In contrast, the lower leaflet lipids do not show a preference to localize around the 
trimer (Figure 4-12 b−d). The lipids form a tight seal around the trimer, which is evident from the 
membranre mid-plane water number density profile that shows three distinct water filled channels 
formed by the lumens of the OmpFs (Figure 4-12 e). The exposed OmpF loops electrostatically 
attract counter ions and form a high density charge ring at the entrance of the trimer (Figure 4-
12f).  
 
Figure 4-12. Average partial number density of membrane components (a) LPA (outer leaflet), 
(b) DPPE (inner leaflet), (c) POPG (inner leaflet), (d) CDL2 (inner leaflet), (e) water (membrane 
midplane), and (f) ions (membrane surface) during two microsecond intervals of trimer 
formation (System 6).  
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The root mean square fluctuations (RMSF) of the amino acid residues were computed over the 
ensemble of structures throughout the simulation (Figure 4-13a). The RMSF values provide unique 
information about the oligomeric state of a protein. For example, dynamic residues exhibit larger 
fluctuations from their reference structure and can be a signature of instability. Notably, the L2 
residues in the OmpF dimer (Figure 4-13) show large fluctuations (0.4 nm) compared to the other 
loops and the β-strand regions. Since L2 has a significant role in latching one monomer to its 
neighbor, these large fluctuations become attenuated with trimer formation. Higher RMSF values 
were observed for a few residues (6, 52 and 304), in the OmpF turns did not diminish upon 
oligomerization. In the dimeric state, the OmpF-OmpFʹ contact is not fully established and the 
G19-G135 intermonomer distance averages 2.05 nm, whereas in the fully formed trimer, the 
separation distance reduces to 1.22 nm (Figure 4-13b). Evidence of high structural flexibility of 
the monomer was obtained computing the RMSD of the structures in each oligomeric state (Figure 
7c). The average RMSD values for the trajectory were consistently higher for the monomer (0.25 
nm), followed by the dimer (0.20-21 nm), and then the trimer (0.18-0.19 nm), indicating higher 
structure flexibility of monomer and a stable trimer, as expected. Another indicator of protein 
structural flexibility is the radius of gyration (Rg), which refers to the distribution of the 
components of an object around a center of mass of the molecule. The Rg provides a measure of 
the compactness of OmpF porins in different oligomeric states (Figure 4-13d). The avagere Rg 
values per monomer for monomeric, dimeric, and trimeric forms are 2.12, 2.09, and 2.04 nm, 
respectively. The OmpF trimer with lowest Rg exhibits the tightest packing, consistent the RMSD 




Figure 4-13. Dynamical properties of OmpF monomersa (orange, System 3), dimerb (green, 
System 3) and trimercc (blue, System 6) during self-assembly. (a) Root-mean-square fluctuations 
of backbone beads, (b) G19−G135 pair separation distance, (c) overall root-mean-square 
deviation, and (d) Rg of the protein as a function of time.  In panel (a), the shaded (light blue) 
regions show the OmpF loop domains (L1−L8). 
4.4.2.2 Comparison of self-assembled OmpF trimer and native structure 
The detailed analysis of the structural and thermodynamic properties of the self-assembled OmpF 
trimer with the X-ray crystal structure (pdb:4LSF) showed remarkable agreement. The global 
RMSD of the assembled OmpF relative to X-ray structure was 2.161 Å, which is a relatively small 
number indicating a very high similarity. Further comparison of the Cα-backbone for individual 
monomers relative to the X-ray structure shows 1.99−2.11 Å RMSD (Table 4-4). The β-barrel, 
loops, and turn motifs of the assembled structure also show small deviations ranging from 1.12–
1.89 Å. The extracellular loops are longer and have more flexibility than the periplasmic turns so 
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it is expected that their deviations are slightly larger than the turns. Further, the total and buried 
surface areas of the trimers were computed for comparison.  The buried surface area provides a 
measure of the surface-to-surface contacts between the monomers within the trimer. The total 
surface area of the assembled trimer was 40483 Å2, which is within 0.4% of the crystal structure’s 
surface area of 40296 Å2. Similarly, the buried surface area of the assembled trimer (8995 Å2) was 
also found to be within 1.5% of the native structure (8861 Å2 ). 
Table 4-4. RMSD (Å) of self-assembled trimer (OmpF-OmpFʹ-OmpFʺ) relative to the X-ray 
crystal structure (pdb:4LSF).  
 
Monomersa Cα β-barrel Loops Turns 
OmpF 1.99 1.12 1.73 1.89 
OmpFʹ 2.10 1.18 1.77 1.81 
OmpFʺ 2.11 1.13 1.69 1.88 
aLabels OmpF, OmpFʹ, OmpFʺ represent the three monomers that consitute the trimer. 
4.4.2.3 Mechanism and thermodynamics of OmpF oligomerization 
The self-assembly simulations revealed the dynamics of the trimer formation, but not the 
thermodynamics of the process. To compute the thermodynamic stability of a dimer relative to 
well-separated monomers, umbrella-sampling simulations were performed to dissociate the dimer 
along the intermonomer separation coordinates. Similarly, the trimer was dissociated into a dimer 
and a monomer. The dissociation of the dimer into two well-separated monomers required 26±1 
kcal/mol, whereas dissociating a trimer into a dimer and monomer required 56±4 kcal/mol (Figure 
4-14). Both simulations were performed while the proteins were embedded in LPA-phospholipid 
membrane to capture the contribution from the asymmetric membrane environment. The 
importance of membrane asymmetry has been emphasized in prior computational and in vivo 





Figure 4-14. Potential of mean force profiles for unbinding of the dimer (System 8)  and trimer 
(System 9) interfaces along the interseparation distance coordinate of the interacting pair. Error 
bars calculated by Bayesian bootstrapping method are shown in the same color. 
 
The thermodynamic stability of the dimer relative to monomers in the LPA-phospholipid 
membrane indicates that the first step of the assembly process is the pairing of monomers. This 
finding is consistent with the in vitro and in vivo ability of OMPs to form oligomers in the outer 
membrane.22 Our results indicate that two monomers diffusing independently in the outer 
membrane will form a stable dimer if they interact in the correct orientation. Interestingly, 
thermodynamic data suggests that the further oligomerization of dimer to trimer can occur via two 
different pathways: (a) Path I—the dimer interacts with a monomer to form the trimer (observed 
in the simulations), and (b) Path II—the dimer interacts with another dimer to form a trimer and a 
lone monomer (not observed in the limited simulation time). Although both paths are feasible 
(Figure 4-15), Path II involves interaction between two slowly diffusing dimers that need to 
114 
 
interact in the correct orientation to cause dissociation of one dimer in the process of forming a 
trimer. The transition state for dimer-dimer interaction is expected to have a higher barrier. It is, 
therefore, not entirely surprising that Path II was not observed in the 48 µs of simulation time. 
However, another factor contributing to the choice of Path I or II would be the relative population 
of monomers versus dimers in the bacterial membrane during oligomerization. 
 
Figure 4-15. A schematic showing two possible pathways that lead to OmpF trimer formation. 
 
4.4.2.4 Interaction of OmpF timer with membrane lipids 
The membrane lipids provide a tight seal around the OmpF to direct the passage of water-soluble 
nutrients through the trimeric nanochannels. The lipid A tails interact with the hydrophobic 
residues of the β-barrel and the phosphates in the lipid A head groups interact with the positively 
charged residues in porin loops. In vitro experiments have demonstrated that irrespective of the 
core and O-antigen domains, lipid A binds to the OmpF trimer. The cross-sectional view of the 
membrane midplane shows a water-filled OmpF lumen with water absent in the rest of membrane 
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(Figure 4-12).  The water density profile shows the distinct footprint of homotrimeric water 
channels for LPC membrane (Figure 4-12e). Overall, we observe that like many integral membrane 
proteins, OmpF porins assemble to form oligomeric structures in lipid microenvironment. Despite 
the extensive hydrogen-bond network that maintains the β-barrel tertiary structure of the OmpF, 
specific weakly stable regions of the β-barrel remain, which drive OmpF oligomerization. OmpF 
has been observed as a trimer in both in vivo and in vitro experiments. The assembly of OmpF 
monomer into oligomers was observed in MT1 and MT3 bilayers (Systems 1, 2, 3, and 6). In 
systems with LPC outer leaflet (Systems 4, 5 and 7), the diffusion of OmpF monomers at 310 K 
was limited and even with 48 µs of simulation time, stable dimers or trimers were observed. This 
implies that we will need to perform these simulations at a higher temperature (T> Tm) and for 
longer times.  However, formation of oligomers is not restricted to a specific membrane 
composition. In fact, OmpF oligomers were observed in symmetric phospholipids membranes that 
we tested (Figure 4-16). In addition, there have been reports of OmpF assembly in asymmetric 
lipopolysaccharide membranes,56 vesicles, and detergents.22 The lack of preference for a 
membrane environment suggests that the surrounding lipids do not provide the required stability 
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Figure 4-16. Dimer formation in different membranes. A). Dimerization of OmpF monomers in 1-
Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) bilayer (OmpF: cyan, NH3
+, PO4
-: 
pink, acyl chains: white). B). Dimerization of OmpF monomers MT1 bilayer (OmpF: cyan, SYB, 
XYA: yellow, acyl chains: white, DPPE: orange). C). Dimerization of OmpF monomers in MT3 







The dynamics of OmpF trimer assembly in E. coli outer membrane were studied in coarse-grained 
molecular dynamics simulations. Motivated by the importance of bacterial membrane lipids in 
protein assembly, we developed a coarse-grained parameter set for E. coli membrane lipids. 
Membrane properties such as area per lipid, hydrophobic thickness, and phase transition 
temperature were benchmarked against available experimental and computational data. 
Development of the coarse-grained lipids was crucial in avoiding the computational bottleneck 
involved in long timescale self-assembly simulations. Multiple simulations starting from OmpF 
monomers embedded in asymmetric membrane were performed to determine the mechanism and 
thermodynamics of the OmpF assembly in bacterial outer membrane. Simulations revealed two 
key steps in OmpF trimer formation. In the first step, two monomers interact via specific 
complementary protein-protein interfaces to yield an asymmetric dimer, with a −26±1 kcal mol−1 
free energy change. The root-mean-square fluctuations of the dimer residues show flexibility in 
loop regions, especially in the L2 latching loop, suggesting that the dimer is not fully structurally 
stabilized via the single protein-protein interface. In fact, the partially stable dimer acts as a 
template for the attachment of a third OmpF monomer that yields a C3 symmetric trimeric 
structure. Formation of the trimer from the dimer and a monomer is the second step of the OmpF 
oligomerization process and it is associated with a −56±1 kcal mol−1 free energy change. The self-
assembled trimer showed excellent agreement with the X-ray crystal structure of OmpF trimer 
with a global root-mean square deviation of less than 2.2 Å. Based on thermodynamic data of the 
two-step assembly process, an alternate path to trimer formation is presented which involves 
interaction of two dimers in the second step. Although a dimer-dimer interaction did not yield a 
trimer in our current set of simulations, likely due to limited simulation time, such a step is 
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thermodynamically feasible with an associated −30 kcal mol−1 free energy change. Overall, we 
observed that OmpF porins self-assemble to form dimeric and trimeric structures in lipid 
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The continued emergence of antibiotic-resistant organisms has severely depleted our arsenal of 
effective antimicrobials. Ionic liquids (ILs), or molten salts, and their close relatives, deep eutectic 
solvents (DESs), show great promise as antibacterial agents. Understanding the mechanism by 
which ILs and DESs attack bacterial cells is key to ensuring that design of IL-based biocides impart 
maximum efficacy with minimal toxicity, while also avoiding the potential for the target organisms 
to become resistant. Here we report the antibacterial attributes of a set of choline and geranic acid 
(CAGE)-based ILs and DESs and identify the mechanism by which they interact with the Gram-
negative cell wall of Escherichia coli.  Four CAGE variants with varying ratios of choline and 
geranic acid were synthesized and tested for their antibacterial activity (1:4, 1:2, 1:1 and 2:1 
choline:geranic acid). The minimum bactericidal concentration required to kill E. coli correlated 
with the geranic acid content. Using molecular dynamics (MD) simulations, we identified the 
mechanism of CAGE action on the E. coli membrane, namely that choline is attracted to the 
negatively-charged cell membrane and consequently inserts geranic acid into the lipid bilayer. This 
study provides the fundamental mechanism of the action of choline-based ILs on bacteria, and 









5.2 INTRODUCTION  
Ionic liquids (ILs), also known as molten salts, are a broad class of compounds most commonly 
described by their low melting points (<100 °C) and low volatility. Common IL cations 
(imidazolium, pyridinium, ammonium and phosphonium) can be combined with a variety of 
anions, all of which can be further functionalized, to create a diverse set of compounds.  Over the 
last two decades, ILs have become popular as green alternatives to volatile organic solvents used 
in the chemical industry. 1 
ILs have been recognized as effective disinfectants for almost a century, but their systematic 
investigation as antibacterial and antifungal agents is a relatively new phenomenon. In 1996 
Pernak and Skrzypczak reported a correlation between the concentration of an imidazolium 
chloride IL and its minimum inhibitory concentration against bacteria.2 Other studies followed to 
confirm this relationship and provide a second mechanistic hypothesis, namely that an IL’s 
antibacterial activity is correlated with the chain length of its alkyl chain.3-9 Several studies 
postulated that aliphatic chains of ILs insert into the bacterial membrane with a mechanism similar 
to that used by surfactants or pesticides. Other studies attributed the functionality of ILs to the 
inhibition of acetylcholinesterase because of the cation.10, 11  
Molecular dynamics (MD) simulations have been used to gain insights into the action of select 
imidazolium ILs on model lipid bilayers.12-14 These simulations showed that imidazolium cations 
interact with the polar head groups of the lipids and insert their hydrophobic tails into the 
membrane. The interactions, however, are highly dependent on the charge and structure of the 
cation, the counter anion, as well as the complexity of the membrane lipids. Literature studies on 
ILs have focused on simple phospholipid bilayer models as surrogates for bacterial membranes 
due to the lack of available force fields for the Gram-negative bacterial outer membranes. 
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Moreover, the atomistic MD simulations have been limited to short timescales (hundreds of 
nanoseconds) that are unable to provide adsorption kinetics of an IL cation on bacterial 
membranes. In recent years, there have been advances in coarse-grained force field libraries for 
bacterial membranes that can aid in elucidating the IL-induced morphological reorganization of 
the bacterial membranes.15-19    
Despite experimental and computational investigation into the interaction of ILs with lipid 
membranes, the exact molecular mechanism remains unknown, including the secondary effects of 
membrane disruption on cellular signaling and other cellular functions.20 The lack of a complete 
mechanistic description hampers the effective development of antimicrobial ILs, especially as it 
pertains to avoiding imparting resistance. Combining a full mechanistic knowledge with the fact 
that IL properties (hydrophilicity, hydrophobicity, density, viscosity, conductivity, and polarity) 
can be widely and readily tuned could provide a wealth of new IL-based antimicrobials with 
maximum efficacy and minimum toxicity.  
Using a combination of experimental and simulation techniques, we investigated the antibacterial 
activity and mechanism of a set of choline (or cholinium)-based ILs on a Gram-negative bacterium, 
Escherichia coli. While imidazolium and pyridinium-based ILs are widely used as solvents, 
choline, a quaternary ammonium cation, is generally regarded as more benign, and therefore a 
good choice for antibiotics. Studies have reported antibacterial properties of choline-based ILs and 
deep eutectic solvents (DESs, a mixture of charged and neutral species), using a variety of 
counterions or functionalizing the choline cation.6,7,21,22,23 Using geranic acid, a highly 
hydrophobic molecule with an 8-carbon backbone, as a counterion, we synthesized 4 choline-
geranic acid (CAGE) formulations, varying the choline bicarbonate and geranic acid ratio:  1:4, 
1:2, 1:1 and 2:1. The 1:1 CAGE is a true IL, while the other 3 are DESs composed of a cation:anion, 
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choline:geranate pair plus additional neutral species, either geranic acid (1:4, 1:2) or choline 
bicarbonate (2:1). Each variant was tested to determine the minimum concentration required to kill 
E. coli, and MD simulations were performed to compute the interfacial properties of CAGE 
variants with E. coli, as well as choline bicarbonate, pure geranic acid, and sodium-substituted 1:4 
CAGE.  
5.3 METHODS 
A cuboidal simulation box comprising of two coarse-grained membrane patches (10×10 nm2) in 
the xy-plane with 81 LPC (lipid A and core oligosaccharides without o-antigen) and 243 DPPE 
lipids each were built using a locally modified version of membrane generator script called 
insane.24 The two membranes were stacked along the z-direction (4 nm spacing) with the LPC 
leaflets oriented towards the center of the box. The intermembrane space was filled with CAGE 
and the remainder of the simulation box was solvated with explicit coarse grained MARTINI 
water.25 The CAGE components were coarse grained using the PyCGtool and the MARTINI four-
to-one mapping protocol.26,27 The electroneutrality of the system was maintained using hydrated 
Ca2+counterions. The two-membrane setup was adopted to compartmentalize CAGE toward the 
outer LPS leaflet to mimic experiments and prevent issues that may arise due to periodic boundary 
conditions along the z-direction. The simulation setup was repeated for all seven CAGE variants. 
The GROMACS molecular dynamics package (version 5.1.2) was used to perform all 
simulations.28,29 Energy minimization was performed using the steepest-decent algorithm with a 
20 fs time-step until the maximum force on any bead was below the tolerance parameter of 10 
kJmol−1nm−1.30 Periodic boundary conditions were applied in all three dimensions. The NVT 
(constant number of particles, volume, and temperature) and NPT (constant number of particles, 
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pressure, and temperature) equilibration runs were performed for 0.2 µs. Semi-isotropic pressure 
coupling was used, and systems were maintained at 1 bar using the Berendsen barostat with time 
constant, τp = 4.0 ps.
31 Temperature was maintained at 335 K by independently coupling the lipids, 
and the solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The neighbor list was 
updated every 25 steps using 1.4 and 1.2 nm for short-range van der Waals and electrostatic 
cutoffs, respectively. The production NPT simulations were performed for 8 µs or 16 µs for all 
systems.  
Post simulation analyses were performed using in-built GROMACS utilities and in-house python 
scripts. To quantify the CAGE and the membrane interaction, we developed an in-house script to 
compute the number of contacts that CAGE components make with E. coli membrane. In this 
analysis, we defined the entire E. coli membrane as one unit, which includes β-(1→6)-linked D-
glucosamine disaccharide head group linked to six acyl carbon chains, the core oligosaccharide 
domain and the lower phospholipid leaflet. A contact was counted when a CAGE component 
molecule was within a 1.1. nm cut-off distance with any part of the membrane. Molecular 
visualization and graphics were generated using visual molecular dynamics (VMD) software.32 
5.4 RESULTS 
The MD simulations were performed in the coarse-grained representation to provide a long 
timescale comparison of CAGE penetration and partitioning in the E. coli outer membrane. The 
MD simulation results show that the choline geranate pair has a unique cooperative penetration 
profile into E. coli membranes.  The quaternary ammonium choline cation with its short hydroxyl 
alkyl chain is sufficiently small to penetrate the LPS domain and form stable ionic interactions 
with the negatively charged membrane. The presence of choline also facilitates the penetration of 
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geranate, which acts as short chain fatty acid chain and inserts itself into the lipid A tails. The 
negatively-charged head group of geranate remains above the hydrophobic tails and is stabilized 
by the embedded cholines.  
Focusing on the simulation results of choline bicarbonate and 2 CAGE variants—choline 
bicarbonate, 2:1, and 1:1 (i.e. without free geranic acid), it is clear that the positively charged 
choline easily penetrates the E. coli’s membrane and binds to the negatively charged core and lipid 
A head groups. The simulation snapshots (Figure 5-1) of the three variants show that in each case, 
choline is trapped within the negatively charged core and lipid A head groups. A higher choline 
concentration in 2:1 variant leads to higher density in the core LPS head groups (Figure 5-1b). It 
is evident from the geranate density profiles of geranate that it penetrates the outer LPS leaflet 
(Figures 5-1 b-c). The contact plot shows how CAGE components penetrate the membrane as a 
function of time. In the beginning of the simulation, most of the CAGE components are on the 
surface so there are fewer contacts, and as time goes by, the CAGE components disperse into the 
membrane, creating more contacts. The CAGE-membrane contact analysis shows as choline 
continues to penetrate the membrane until equilibrium is achieved in 6-7 µs. Compared to choline, 
the geranate contacts are 6 to 8 times lower in 2:1 and 1:1 CAGE, respectively. Unlike geranate, 
the bicarbonate ion, devoid of the alkyl chain, does not penetrate the LPS (Figure 3a), which 




Figure 5-1. Comparison of CAGE variants (a) Choline bicarbonate (b) 2:1 and (c) 1:1. For each 
variant, the panels show the molecular simulation box, the number density of choline, the number 
density of bicarbonate or geranate, and the number of contacts as function of simulation time.  
 
In the case of 1:2 and 1:4 CAGE variants, in addition to choline and geranate, the uncharged 
geranic acid molecules penetrate both the outer and inner leaflets of the membrane (Figures 5-2 a-
b).  The abundance of geranic acid in 1:4 CAGE results in very high membrane penetration, which 
explains the high efficacy observed in experiments (Figure 5-2b). The geranic acid penetration in 
1:2 CAGE is only half of that observed in 1:4 CAGE (Figure 5-2a).  However, in the absence of 




Figure 5-2. Comparison of CAGE variants (a) 1:2 (b) 1:4, and (c) pure geranic acid. For each 
variant, the panels show the molecular simulation box, the number density of choline, the number 
density of geranate, the number density of geranic acid, and the number of contacts as function of 
simulation time.  
 
To further investigate the role of choline, we tested a 1:4 CAGE variant in which choline was 
replaced with Na+ ions (Figure 5-3). Just as choline, the Na+ ions penetrate the LPS core and make 
similar contacts with the membrane lipids, but being a hard cation, Na+ ions do not interact 
cooperatively with softer anions such as geranate and geranic acid molecules to facilitate their 
penetration. The substitution of choline with Na+ demonstrate that choline is vital for the 




Figure 5-3.  Comparison of Na+ 1: 4 Sodium Geranate. The panels show the molecular 
simulation box, the number density of Na+ ions, the number density of geranate, the number 
density of geranic acid, and the number of contacts as function of simulation time.  
 
5.5 DISCUSSION 
A full understanding of how a candidate antibiotic acts against a pathogen is of upmost importance 
to develop antibiotics with high efficacy and low potential to impart resistance. Since the properties 
of ILs can be finely tuned, a full mechanistic knowledge of their action of cell disruption can allow 
us to the design a wealth of IL-based antimicrobials. CAGE ILs and DESs are easily synthesized 
via an ambient temperature salt metathesis reaction using commercially sourced and FDA-listed 
GRAS reactants choline bicarbonate and geranic acid. Choline is a water-soluble essential nutrient, 
made in the liver, and present in phospholipids that are abundant in cell membranes. Geranic acid, 
commonly used as a flavoring agent, is naturally occurring in lemongrass, which has reported 
antimicrobial activity itself.33  
Mechanistic hypotheses for ILs’ antibacterial activity most commonly include cell membrane 
disruption.4,8,9,20 Some studies suggest additional signal interruptions as a result, but what actually 
causes cell death remains unknown. The E. coli outer membrane is comprised of a 
lipopolysaccharide-rich outer leaflet and a 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine 
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(DPPE)-rich inner leaflet. Each E. coli lipopolysaccharide molecule has a core oligosaccharide 
domain and lipid A domains with six and two negative charges, respectively.19 The presence of a 
negatively charged outer leaflet makes the bacterial membrane unique compared to phospholipid 
bilayers and makes it susceptible to penetration by CAGE. In the MD simulations, the density 
profiles and the contact analysis of the seven compounds demonstrate that the negatively charged 
LPS core forms a barrier for geranate and geranic acid. In the presence of choline-containing 
CAGE variants, however, the LPS negative charge is effectively screened and choline is able to 
facilitate the geranate and geranic acid penetration into the membrane. Among the seven 
compounds simulated, 1:4 CAGE has the highest penetration, which explains the high toxicity 
observed in the experiments. Using the CAGE component penetration as a measure of their 
efficacy, the simulation results show the following order of CAGE variants toxicity: 1:4 > 1:2 > 
1:1 > 2:1> choline bicarbonate > pure geranic acid > Na+1:4. The order corroborates with the 
experimentally observed CAGE toxicity.                
There are no previous studies on cholinium-geranic acid salts, however some groups have 
investigated other choline-based ILs for their bacterial activity, and our results are generally 
consistent with these studies. Petkovic, synthesized a group of ILs using a choline cation paired 
with a range of linear alkanoate anions ([CnH2n+1CO2]
-, where n=1-9) and found that the longer 
anion chains resulted in lower MFC values. Choline chloride, tested as a proxy for the choline 
cation alone, showed the lowest toxicity.7  Zhao synthesized a variety of choline-based DESs using 
choline chloride and several different types of hydrogen-bond donors including organic acids, 
amines, alcohols and sugars; only the organic acid-containing DES showed bacterial inhibition.23 
The CAGE mechanism of membrane attraction and insertion, while similar to those suggested for 
cation-substituted ILs, has a unique feature – the hydrophobic long chain can dissociate from the 
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more bulky, hydrophilic cation and penetrate deeper into the membrane. This dissociation ability 
may prove useful in developing highly effective antimicrobial ILs. It is also interesting to note that 
geranic acid is structurally similar to free fatty acids, which have demonstrated bioactivities related 
to chain length and degree of saturation, but poor solubility.34 Combining choline, a hydrophilic 
molecule, with hydrophobic geranic acid may improve its ability to contact cells in aqueous 
environments like wounds. 
 
5.6 CONCLUSIONS 
By varying the ion ratios in CAGE, we were able to show that increasing the geranic acid content 
increases the biocidal activity. Through MD simulations we identified cell membrane disruption 
via choline attraction to the negatively-charged cell membrane and geranic acid insertion as a 
disrupting mechanism. Overall, this study provides the basic mechanism for choline-based IL 
activity on the cell membrane of Gram-negative E. coli. CAGE is a promising new antibacterial 
that kills E. coli with low mM concentrations and exhibits no evidence of imparting vertical 
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Antibiotic resistance has become one of the greatest challenges. Finding new class of antibiotics 
is becoming more urgent when Gram-negative bacteria are becoming more resistance to most 
available antibiotics. The cell envelope of Gram-negative bacteria contains porin proteins, which 
are specific to a few molecules. Understanding molecules transport is urgently needed for the 
rational design of existing and new antibiotics. To quickly and accurately obtain the transport 
pathway of a large set of small molecules, we built a high throughput computational automated 
screening platform. We used P.aeruginosa as the first test of our platform. P.aeruginosa has an 
even narrower outer membrane porins, which make penetration of antibiotics harder. The transport 
of Carbepenem across P.aeruginosa’s major channel, the OccD1, was studied. The detailed 
transport process of Carbepenem was revealed and compared with some reported results. Based 
on the fast and accurate information acquisition ability, the computational platform, which can be 
used to process large numbers of small molecules and extended to more bacterial membrane as 
well as their all identified porins. These results and the platform will help understand the 
permeability of drug candidates and facilitate the drug discovery process.  
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6.2 INTRODUCTION  
Antibiotic resistance has become one of the biggest threats to human health. Even though the 
occurrence of antibiotic resistance is a natural process, the overuse and misuse are becoming the 
primary reasons for accelerating this process to causes higher patient mortality and treatment 
expenses.1, 2 However, the development of new antibiotics cannot catch up with the emergence of 
resistant bacteria.  Since the last discovery of a new class of antibiotics was on 1987, there is a 
huge void in the history of antibiotics development.3 Many major pharmaceutical companies are 
dropping antibiotics development programs now, the low success rate makes the cost higher than 
expectation, antibiotics resistance develops fast after new antibiotics being introduced, which 
makes antibiotics a short-term drug and profits are also reduced. The development of new 
antibiotics needs at least 10 years and over 1 billion dollars, potential antibiotics need to be 
screened out from more than thousands of small molecules, there is a lack of efficient screening 
technique, which can help lower the investment.4 This technique should be able to easily acquire 
the antibiotics transport pathway through the bacterial membrane in a fast manner because the 
membrane has been proved to be the main barrier for most small molecules. It is worth noting that 
Gram-negative bacteria are becoming resistant to most available antibiotic drugs. The complicated 
outer membrane of Gram-negative bacteria was found to be able to help them develop antibiotic 
resistance easily and quickly.2 
The outer membrane of Gram-negative bacteria comprises lipopolysaccharides (LPS) as outer 
leaflet, mixture of phospholipids as inner leaflet and outer membrane proteins (OMPs) as pores to 
allow transport of small molecules. The rigid outer membrane forms the first line of defense, which 
makes the Gram-negative bacteria much harder to treat than Gram-positive bacteria.5-7  
Understanding the interactions between this unique membrane and small molecules is essential to 
146 
 
guide the development process of new antibiotics. To achieve this goal, many potential candidates 
need to be tested from some small molecules libraries, e.g. Microsource SPECTRUM Collection, 
ChemBridge Diversity Set Library, etc. To facilitate this process, computational approaches 
should be employed to comprehensively understand the details at the molecular level and screen 
out the most promising antibiotics from these drug candidates to boost the drug discovery pipeline.  
Recently, with the development of Computer-aided drug design (CADD), computational 
approaches have been widely used to guide and accelerate the early-stage development of new 
compounds and reduce the cost.8, 9 Molecular dynamics (MD), which is a computer-based 
simulation method to study chemical systems and provide physical behavior of each atom or 
molecule in the system for nanoseconds to microseconds, can be employed to gain insights into 
the actions of small molecules on bacterial outer membrane or membrane proteins in molecular 
level to help develop robust antibiotics.5-7, 10 
All-atom MD and Coarsed-grained MD are being widely used to perform simulations. All-atom 
MD provides us detailed interactions between each atom but needs more computing resources and 
time, so it is too expensive for All-atom MD to achieve long simulation time and simulate 
complicated systems. MD in coarse-grained (CG) level could help achieve longer time scale and 
larger system sizes by merging several atoms into one bead to reduce the degree of freedom so 
that people can explore more complex systems.11-14 Martini force field is a popular used CG force 
field that provides us a variety of parameters of LPS, membrane lipids, amino acids, proteins, 
solvents and ions.15-21 We built our CG representation of simulation systems using Martini force 
field, comprising Gram-negative bacterial outer membrane with or without OMPs embedded 
depending on the specific bacteria, target molecule and solvents to explore the exhaustive transport 
behavior of target molecule through the membrane or OMPs into the periplasmic space. The 
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thermodynamic and kinetic data of the transport can be obtained by our CG molecular simulations 
as well as the molecule-membrane/molecule-protein interactions. To alleviate the burden of 
building new systems with different bacteria membranes, OMPs and small molecules, we made an 
automatic simulation control algorithm to easily achieve our goals, which is a computational 
automated screening platform that can quickly generate the data for further analysis. However, to 
validate the reliability of the computational platform, we had to prove that the simulation results 
could reproduce bench experimental or atomistic simulation data.  
What we noticed was, the outer membrane carboxylate channel D (OccD), the largest family of 
substrate-specific proteins in P. aeruginosa, has been well studied in recent years.22-27 OccD, 
known as the main channel for majority of small molecules such as basic amino acids, is a barrel 
protein with 18 β-strands connected by large extracellular loops and short turns and its x-ray 
structure has been determined. Additionally, OccD1 is the important gateway for carbepenem 
antibiotics, which are being widely used to treat infections caused by P. aeruginosa.28, 29 
Carbepenems belong to β-lactam antimicrobial agents, which are able to bind the penicillin binding 
proteins (PBPs) to inhibit P. aeruginosa’s cell wall synthesis. The advantage of using 
Carbepenems is their excellent stability against most β-lactamases.30, 31 However, P. aeruginosa 
acquires resistance against carbepenems by changing their PBPs’ structure, expressing efflux 
pumps and lower their OccD protein’s permeability or stopping expressing these specific porin 
proteins.32-34 Understanding the mechanism of Carbepenems’ transport is imperative to reduce the 
threat of P. aeruginosa, which has been listed as the top 3 pathogenic bacteria by World Health 
Organization in 2017. Recently, the penetration of Carbepenems across P. aeruginosa’s OccD1 
protein has been studied in detail, elaborating the specific penetration process, which could be used 
as benchmark to validate the accuracy, reliability and feasibility of our computational platform 
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when CG force field parameters of P. aeruginosa are already available, which was done by our 
previous work.5, 25, 31 
In this work, we reported the development of a novel computational automated screening platform 
(CLASP) for small molecules screening. Six carbepenems including doripenem, ertapenem, 
biapenem, panipenem, meropenem, imipenem and OccD1 porin protein of P. aeruginosa were 
chosen as the first test for our newly built CLASP (Table 6-1). After 6 independent simulations, 
the 6 carbepenems showed excellent behavior of penetration profiles, which reproduced the 
experimental findings and provided more insight into the penetration process within a very short 
time. Based on our performance tests, each simulation can be finished within 45 minutes using our 
available computer resources and could be reduced when adopting high performance computing. 
Our results provided an automated computational platform for exploring penetration process of 
small molecules, which can be applied to all CG lipid bilayer and available bacterial outer 
membranes, atomistic models are applicative by mapping to CG modeling using martinize.py18 
and PyCGTOOL.35 This platform developed a new method of optimizing lead compounds and 
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6.3.1 Simulation details 
Simulation set-up: The GROMACS molecular dynamics package (5.1.2) was used in the present 
work.36 Energy minimization simulations were performed using the steepest-decent algorithm with 
a 20 fs time-step until the maximum force on any bead was below the tolerance parameter of 10 
kJ mol−1 nm−1.37 Periodic boundary conditions were applied in all three dimensions. The NVT 
(constant number of particles, volume, and temperature) and NPT (constant number of particles, 
pressure, and temperature) equilibration runs were performed for 0.2 µs.38, 39 Semi-isotropic 
pressure coupling was used and systems were maintained at 1 bar using the Berendsen barostat 
with time constant, τp = 4.0 ps.40, 41 Temperature was maintained at 325 K by independently 
coupling the lipids, proteins, and the solvent to an external velocity rescaling thermostat with τT = 
1.0 ps. The neighbor list was updated every 25 steps using 1.4 and 1.2 nm for short-range van der 
Waals and electrostatic cutoffs, respectively. The production NPT simulations were performed for 
2 µs. 
Potential of Mean Force (PMF) Calculations: To compute the PMF curves, we built the P. 
aeruginosa lipopolysaccharide with OccD1 porin protein embedded in 10×10 nm2 membrane 
patches. The membrane was equilibrated while keeping the proteins position-restrained for 0.5 µs 
at 310 K. The restraints were then removed and pull simulations were performed along the reaction 
coordinate defined by separation of the center of mass (COM) of the interacting OccD1 while still 
embedded in the membrane. A single diglycine was pulled with respect to the COM of its position-
restrained OccD1 protein. A harmonic potential with 5000 kJmol-1 nm2 force constant was used 
for the pull. A total of 100 independent Umbrella Sampling (US) windows were extracted along 
151 
 
the reaction coordinate for both systems, and each window was simulated for 0.2 us. The weighted 
histogram analysis method (WHAM) along with bootstrapping was used to extract the PMF 
profiles.42 
Table 6-1 System details of Carbepenem-OccD1 simulations 
 
6.3.2 Method development 
The CLASP algorithm has been developed to accelerate the simulation process for calculating 
PMF using Martini Force Field and subsequent data processing and analysis. The aim is to make 
the tedious Umbrella Sampling simulations automated and quickly obtain some important 
biological data. Although the CLASP was designed for CG simulations, atomistic models are also 
supported by converting to CG model using Martinize or PyCGTOOL. The work flow is shown 
in Fig.6-1.  
Atomistic or Coarse grain structure of proteins and molecules as well as the topology are taken as 
the input files, different kinds of membrane can be built by insane.py with interested proteins 
embedded,43 10 Gram-negative bacterial outer membrane can be also generated using in-house 
modified insane.py called BOB.py (Bacterial Outer membrane Builder). A short Energy 
minimization, NVT and NPT are needed after building the membrane-protein-solvent system 
followed by a 2 μs production NPT simulation to establish the starting configuration. The pre-
Antibiotic 
Inner   Outer   No. of 
T (K) t (s) 
DPPE  LPA DPPE  carbepenem OccD 1 water ions 
Doripenem  144  55 6  1 1 6507 127 325 200 
Ertapenem 144  55 6  1 1 6507 127 325 200 
Biapenem 144  55 6  1 1 6507 127 325 200 
Panipenem 144  55 6  1 1 6507 127 325 200 
Meropenem 144  55 6  1 1 6507 127 325 200 
Imipenem 144  55 6   1 1 6507 127 325 200 
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prepared molecules input files are inserted into the well-designed N positions across the protein 
channel to generate N configurations by gmx insert-molecules. Each one will be taken as the 
starting configuration for the US window and will be assigned an independent directory to perform 
US run. Finally, the PMF curves will be generated and trajectories will be used for further analysis 
to obtain useful biological information. 
  




6.3.3 CLASP performance 
In this work, all simulations were performed in GROMACS as mentioned in the method. The 
performance is provided for The Academic Virtual Hosting Environment (AVHE) computer 
clusters provided by Syracuse University. Table 2 shows the performance for different number of 
nodes and openMP threads used for the umbrella sampling simulations. The best performance we 
calculated was about 3200 ns/day and only 45 mins are needed for the simulations. With enough 
nodes provided, our platform can be used in a very fast manner. 
Table 6-2 Simulation Performance 
# of Nodes # of OpenMP Rate (ns/day) Time (mins) 
2 2 637.775 225 
4 2 889.276 161 
8 2 1875.672 76 
16 2 1847.037 77 
24 1 2346.15 60 
24 2 3202.917 45 
24 3 2207.56 65 
 
6.3.4 Carbepenem coarse graining  
The coarse grain parametrization of carbepenem was developed based on MARTINI many to-one 
mapping in which on average four heavy atoms are mapped into one bead. The detailed mapping 
scheme of six carbepenem were shown in Fig.6-2. The β lactam ring was assigned four beads (SP1, 
SP3, SC5, SQa) and the side chain linked to β lactam ring through a sulfur was assigned different 
beads types based on each one’s  specific side group. PyCGTOOL was used to generate the initial 
system coordinates and topologies for CG simulations. The validation was also performed to 
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compare the CG model with the atomistic structure using PyCGTOOL tutorial to ensure the high 













Figure.6-2 The coarse grained mapping scheme showing Martini beads of types Q/SQ (cyan), P/SP 
(orange), C/SC (grey), N/SN (green), A) Doripenem B) Ertapenem C) Biapenem D) Panipenem 






Post simulation analyses were performed using CLASP data analysis scripts including some in-
built GROMACS utilities, and external software suites such as YASARA for protein alignment 
with X-ray crystal structure and CAVER for analysis and visualization of porin channels. 
Molecular visualization and graphics were generated using VMD, PyMol and YASARA.44-47 
 
6.4 RESULTS 
In this work, we showed the ability of CLASP to obtain the transport barrier of small molecules, 
interactions between small molecules and channel proteins, key residues involved during transport 
and the orientation of small molecules during the whole transport process. We used our selected 6 
carbepenem as examples. Based on the size and coarse grain mapping of these 6 carbepenem, I 
categorize them as 1) Doripenem and Ertapenem, which have 7 and 8 beads, respectively 2) 
Panipenem, Meropenem and Biapenem, which contain 6 martini beads and 3) Imipenem, which 











Case study 1: Doripenem and Ertapenem 
The PMF profiles of the six-selected carbepenems were obtained using the automated umbrella-
sampling simulations implemented in CLASP. One hundred of configurations were generated 
along the OccD1’s channel and run in independent simulations. All simulations were performed 
while the protein was embedded in P. aeruginosa’s lipidA-phospholipid membrane. The free 
energy profiles of Doripenem and Ertapenem carbepenem were shown in Fig.6-3. There is a 
common binding site around Displacement (D) = 2.3 nm for Doripenem and Ertapenem, which is 
the landing site of carbepenem in the entrance of OccD1’s channel that right above loop 7. The 
region from D= 2.5 nm to D= 4.7 nm was found to be the constriction zone of OccD1, which has 
narrower cavity compared with other regions of the protein. Doripenem and Ertapenem showed 
transport barrier about 52 and 48 kJ/mol to go through this highly confined region.  
 
Figure.6-3 PMF of Doripenem (Navy blue) and Ertapenem (red) 
The PMF profile of Doripenem and Ertapenem showed us two interesting sites inside the protein, 
D= 2.3 nm and D= 4 nm. At D = 2.3 nm, both of them had favorite binding sites due to the 
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formation of some intermolecular interactions. Doripenem and Ertapenem have energy well-depth 
of ~ 8 kJ/mol and ~17 kJ/mol, respectively, which shows that Ertapenem has stronger binding 
affinity towards this landing site of OccD1. 
The detailed transport process of carbepenem have been studied over the past few years. It is well 
known that carbepenem need the assistant of some specific amino acids to successfully transport 
through the OccD1, the functions of arginine ladder has been studied carefully recently to reveal 
the importance of it to mediate the penetration of carbepenem. Arginine would interact with the 
carboxylate of carbepenem to stabilize the binding of carbepenem and OccD1. The arginine ladder 
includes Arg 30, Arg 39, Arg 319, Arg 337, Arg 389, Arg 391 and Arg 410, which extend through 
the constriction zone, would guide the permeation of carbepenem toward the inside of OccD1, 
leading to a successful penetration. In order to prove the importance of the arginine ladder during 
the carbepenem’s penetration, CLASP was designed to be able to catch the interactions between 
small molecules and amino acids of the protein channel in a dynamic way and give us a 
comprehensive view of the transport process, which is an important function to find out the most 
important residues that can facilitate the transport process or block the penetration so that we can 
modify or design small molecules on a basis of these results. Here we report the application of 
CLASP to capture how small molecules contact with all amino acids of the protein to reveal the 
participation of arginine ladder in carbepenem penetration.  
Firstly, the trajectories of Doripenem and Ertapenem penetrating the OccD1 were generated and 
then analyzed by CLASP to calculate the contact or collision between them and the amino acids 
of OccD1. The contact was calculated based on the center of mass distance between the them and 
the specific amino acids, when the distance was smaller than van der Waals force cut-off (1.2 nm), 
they would be recognized as having contact. By using this method, the total number of contacts 
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between the Doripenem and Ertapenem molecule and all amino acids of OccD1 were recorded.  
The most notable six amino acids that have the highest number of contact were shown in Fig.6-4 
for Doripenem and Ertapenem. It showed that Tyr, Arg and Phe had the most significant contact 
with Doripenem and Ertapenem. During penetration, doripenem and Ertapenem molecule would 
make significant contacts with tyrosine first followed by very frequent contacts with arginine 
Phenylalanine also showed high contact because most phenylalanine within OccD1 are adjacent 
to arginine so they showed similar contact. These results highlighted the important amino acids 
involved during the penetration, modifications or mutations of these amino acids may lead to 





Figure.6-4 Amino acid – Carbepenem contacts A) Doripenem B) Ertapenem. Tyrosine (blue), 
Arginine (red), Phenylalanine (yellow), Threonine (green), Histidine (light green), Lysine (orange) 
 
However, this was still not enough to understand which Tyrosine and Arginine made contributions 
to the contact. Even though it was notable that tyrosine and arginine were critical during the 
penetration process. However, OccD1 includes 26 tyrosine and 16 arginine, not all of them were 
involved in this process. In order to identify the specific tyrosine and arginine involved, CLASP 
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was designed to be able to obtain the contact between the carbepenem molecule and tyrosine, 
arginine of OccD1, respectively using similar method in last paragraph. This result would provide 
us more accurate targets if any modifications or mutations are needed to be done to change 
OccD1’s selectively or permeability. Fig. 6-5 shows the total contact between Doripenem and 
Ertapenem molecule with all tyrosine in OccD1, the assignment of colors was based on the number 
of contacts, tyrosine that has the highest contact with Doripenem or Ertapenem was assigned red, 
then we showed gradually decreasing concentrations in green, cyan, navy blue and gray. Tyr 173, 
Tyr 176, Tyr 305 and Tyr 359 were the most significant tyrosine to interact with both Doripenem 
and Ertapenem. The positions of these 4 red-labeled tyrosine were highlighted in OccD1 in Fig.6-
5 C. Not surprisingly, all red-labeled tyrosine were found at the entrance of OccD1. And the fact 
is the entrance of OccD1 shows high density of tyrosine.  
More importantly, Fig.6-4 revealed the significant participation of arginine. Similar to the tyrosine-
Doripenem/Ertapenem contact map above, the 16 arginine’s contacts with Doripenem/Ertapenem 
were also recorded. Arg 30, 39, 131, 319, 389, 391 were found to be the most significant residues 
to interact with Doripenem and Ertapenem (Fig. 6-6). These residues are located on or near the 
basic ladder or opposite. This finding matched the aforementioned reported results about the 
arginine basic ladder and confirmed the importance of them.41 Ertapenem showed higher contacts 
with tyrosine and arginine due to its bigger size, it contains 8 beads that had higher probability to 
have contact with these amino acid residues. 
The orientation of Doripenem and Ertapenem during the transport were recorded using CALSP 
(Fig. 6-7). The Dij is the z-component of the norm of the interatomic vector connecting the first 
SP1 bead on the β lactam ring and the last bead on the side chain (P5 of Doripenem and SP3 of 
Ertapenem). The magnitude of this vector is about 1 nm and the direction is from SP1 to Qd for 
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panipenem. The magnitude was also calculated to ensure that it would not change during the 
process so that its z-component can be used as a good mark for the orientation. Fig. 6-7 showed 
the changes of Dij, it was clear that the molecule can move freely in the wide and open regions (D= 
0 – 2.5 nm and D > 5nm), but the orientation was restrained in the constriction zone (D= 2.5 – 5 
nm). Moreover, for Doripenem, when D= 3 nm, the Dij was mostly negative, indicating the SP1 
bead was mostly above the Qd bead, when D was close to 3.8 nm, Dij was close to +1 nm indicating 
the Doripenem was almost parallel to the z axis of the protein with SP1 bead ahead, it looks like 
that a flip-flop happened around D= 3.7 nm . However, after D= 4nm, there was a sudden change 
of the orientation to a negative Dij. When D= 4nm, another flip-flop happened again so the Dij 


















Figure. 6-5 Tyrosine - Carbepenem contact A) Tyrosine – Doripenem contact B) Tyrosine – 
Ertapenem contact C) Positions of tyrosine with highest contact 
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Case study 2: Panipenem, Biapenem and Meropenem 
The free energy profiles of Panipenem, Biapenem and Meropenem were shown in Fig. 6-8. These 
three carbepenem have similar binding site around D= 2.3 nm. They have intermediate transport 
barrier about 28, 23 and 22 kJ/mol, respectively, which are significantly smaller than Doripenem 
and Ertapenem. This difference may arise from the bulky side groups that Dorioenem and 
Ertapenem have. It is also interesting that all of them showed similar depth of the binding sites 
about 15 kJ/mol compared with 29 kcal/mol of panipenem, indicating a possible stronger binding 
of panipenem toward OccD1’s binding site at D = 2.4 nm.  
 
Figure. 6-8 PMF of Panipenem (orange), Biapenem (purple) and Meropenem (green) 
In order to catch the important residues, the total number of contacts between the Panipenem, 
Biapenem and Meropenem molecule and all amino acids of OccD1 were computed as described 
in Case study 1 (Fig. 6-9). Same color scheme was used here. It is very clear that tyrosine and 
arginine were also the most significant ones as Doripenem and Ertapenem. Because of the smaller 
size compared with Doripenem and Ertapenem, less frequent contacts were observed for these 3 
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carbepenem. For tyrosine, Tyr 173, Tyr 176, Tyr 305 and Tyr 359 were still found to have the 
highest contacts (Fig. 6-10), which also means most carbepenem have similar preferred “landing 
site” at the entrance of OccD1. For arginine, Arg 30, 39, 131, 319, 389, 391 that from the arginine 
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Figure.6-9 Amino acid – Carbepenem contacts A) Panipenem B) Biapenem C) Meropenem  
Tyrosine (blue), Arginine (red), Phenylalanine (yellow), Threonine (green), Histidine (light 
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Figure. 6-10 Tyrosine - Carbepenem contact A) Tyrosine – Panipenem contact B) Tyrosine – 
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Figure.6-11 Arginine - Carbepenem contact A) Arginine –Panipenem contact B) Arginine –





The orientation of Panipenem, Biapenem and Meropenem were also computed (Fig. 6-12). The 
flip-flop effect was observed in all three carbepenem here. For example, panipenem showed 
lumped Dij = 1 around D= 3.6 – 3.8 nm and suddenly below -0.5 around D= 4 - 4.6 nm, indicating 
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In order to catch the orientation change, we extracted the frames from our simulations to show 
how panipenem transported through D= 3.6 – 4.6 region. Panipenem molecule, its SP1 bead and 
Qd bead were colored skyblue, red and yellow, respectively. The carboxylate group of carbepenem 
(SQa bead) was colored magenta and the positively charge nitrogen in arginine’s guanidino group 
was colored green to better show the positions of the functional groups. The penetration sequence 
was also labeled as 1-5 in Fig. 6-13. When the panipenem molecule was close the constriction 
zone when D > 3.6, it maintained the orientation like step 1 and 2 with carboxylate group pointing 
to the guanidino group of Arg 131, now the Dij is close to +1. When it was moving deeper, the 
opposite arginine would take over the guide function and the panipenem would turn around to face 
to these arginine with carboxylate group pointing to their guanidino group (step 3-4). Then they 
would still maintain this tailfirst shape due to the restrain of the narrow constriction zone until it 
reached the wide region and finally got out of the protein, now the Dij was about -1. The Arg 131 
was working as a transfer station when panipenem was guided by previous arginine in the ladder 
to the later arginine of the ladder in the narrowest region of the constriction zone. Arg 131 is not 
part of the arginine ladder, so its function was rarely investigated in previous studies. By studying 





Figure.6-13 Panipenem penetrating OccD1 constriction zone process. Major arginine involved in 
this process are colored red. 
 
Case study 3: Imipenem 
Imipenem is the smallest carbepenem among the 6 selected carbepenem. It showed the lowest 
barrier of 15.5 kJ/mol (Fig. 6-14). This was correlated with the size of the six carbepenem, based 
on Martini Force Field’s mapping scheme, Doripenem and Ertapenem were mapped to 7 and 8 
beads, respectively, Biapenem, Panipenem and Meropenem were mapped to 6 beads, imipenem 
was mapping to 5 beads (Fig. 6-2). All of them showed no significant barrier after D> 4.7 nm, 
indicating a wide and open protein channel after the constriction zone and the main barrier of 




Figure.6-14 PMF of Imipenem 
From Fig. 6-15, it is obvious that tyrosine and arginine were still the leading amino acids that made 
the most contact with imipenem. Tyr 173, Tyr 176, Tyr 305 and Tyr 359 had the highest contact 
with imipenem (Fig. 6-16 A) and arginine ladder also had high contact with imipenem (Fig. 6-16 
B), which remains the same as other 5 carbepenem. 
 








Figure. 6-16 A) Tyrosine - Imipenem contact B) Arginine – Imipenem contact 
 
The orientation of imipenem during the transport still had less frequent changes in the constriction 
zone, but not as obvious as other 5, which may because of the size of imipenem that allowed it to 
move more freely in the highly confined constriction zone. Flip-flop of Dij were also observed as 





Figure. 6-17 Dij of Imipenem 
6.5 DISCUSSION 
The major applications of CLASP were revealed by the 3 case studies. Transport barriers of six 
selected carbepenem were computed using automated Umbrella Sampling simulations conducted 
by CLASP. The transport barriers showed positive correlation with the size of the molecule. The 
smallest imipenem had the lowest barrier. As D= 2.5 nm all carbepenem have a strong binding site 
toward OccD1. All carbepenem showed similar depth of the binding sites below 20 kJ/mol 
compared with -29 kJ/mol of panipenem, indicating a possible stronger binding of panipenem 
toward OccD1’s landing site of entrance.  
We computed the contacts between all amino acids of OccD1 and the six carbepenem. All of them 
showed similar contact map without any exception. Furthermore, we noticed that tyrosine showed 
significant higher contact with carbepenem when they started entering the channel because of 
tyrosine’s high density in the entrance. Even though there is few research on the functions of 
tyrosine, the importance of tyrosine during the transport should attract more attention.  
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Arginine ladder plays important role in guiding the transport of carbepenem, arginine from the 
arginine ladder formed stable interactions with carbepenem and had high contact with them based 
on hydrophobic interactions/hydrogen bonding plots and contact map. Besides the arginine ladder, 
some other arginine also had high contact with all carbepenem. Arg 131, which is not part of the 
arginine ladder, had high contact with all carbepenem and its function was partly studied in this 
paper. However, all amino acid residues that are involved during the transport should be studied 
carefully. And CLASP is able to catch these important residues accurately and easily. Suitable 
mutations of these identified important residues would provide comprehensive understanding of 
their features 
All 6 carbepenem showed the similar turning behavior, which was achieved with the assistant of 
Arg 131, either from tailfirst to headfirst, or from headfirst to tailfirst depending on their initial 
orientation before penetrating this area. This finding confirmed the guide function of arginine 
ladder as well as the importance of Arg 131. The detailed penetration steps of carbepenem was 
also revealed here, which would be important for amino acid mutation study, modification of 










The spread of resistant bacteria species is becoming uncontrollable in the absence of efficient 
platforms for antibiotic discovery. To facilitate the process of finding more promising lead 
compounds, CLASP was developed to quickly acquire information about the transport process of 
small molecules. P. aeruginosa and its special outer membrane protein OccD1 were chosen as the 
first test of this platform. Six carbepenem were used in this test. CLASP was able to obtain the 
barrier for these carbepenem transport through OccD1 within 1 hour. During the transport process, 
tyrosine and arginine were found to be the most dominant amino acids involved and specific 
residues of two amino acids were also identified, further study on these residues would help 
understand the functions of them. In order to successfully go through the constriction zone of 
OccD1, all carbepenem were guided by the arginine ladder. In this region, the frequency of 
molecular directional changes is significantly reduced. Arg 131, as a transfer stop, could cause 
sudden directional change, even though it is not part of the arginine ladder, its function cannot be 
ignored. These information would guide rational design and modification of antibiotic molecules. 
Overall, we successfully designed the CLASP, and it is a promising computational platform for 
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In this work, force field parameterization of ten Gram-negative bacterial outer membranes has 
been completed. Coarse grained computational models of these ten membranes showed great 
agreement with experimental data. Force field parameters can be downloaded online now for free 
either from our group website or Martini force field website. As an integral part of the cell 
membrane, behavior of OmpF porin protein were also studied. The results highlighted the 
necessity of OmpF to remain trimeric state. The process of OmpF to form trimer were observed 
by simulations. The mechanism of forming trimer was also confirmed.  
After successfully modeling Gram-negative bacterial outer membrane, we applied our coarse 
grained E.coli’s outer membrane to the study of ionic liquids. Molecular dynamic simulations were 
used to reveal the effect of CAGE variants on E.coli’s outer membrane. Combined with 
experimental data from our collaborator, basic mechanism of choline-based IL activity was 
illuminated. This also confirmed the reliability and applicability of our models. 
To best use these models, CLASP was developed to achieve automated screening of antibiotics. 6 
carbepenem were chosen as the first test of CLASP. The results basically confirm the previously 
published conclusions and provide more valuable information. The easy extension of CLASP 
makes it a promising tool to investigate more potential small molecules and help rational design 
of available antibiotics. The process of developing antibiotics will benefit from the information 







7.2 FUTURE WORK 
 
Gram-negative and Gram-positive bacteria both have peptidoglycan in their cell wall, which is not 
included in my work. Coarse grained parameterization of bacterial peptidoglycan has been partly 
done in our group. Mechanism of how antibiotics transport through the entire cell wall of bacteria 
can be achieved in the future.  
A library of coarse grained bacterial outer membranes are needed to improve the applicability of 
CLASP especially for those pathogenic species. Based on available models and identified porin 
proteins, CLASP can already be extended to 10 bacterial as well as their associated porin proteins. 



















Appendix: Tables of parameters for coarse grained E.coli lipid A and 
core oligosaccharides  
Table S4-1. Equilibrium bond length and force constant values for the coarse grained lipid A 
model of E. coli 
Residue Bonds Rmin(nm) Kbond(kJ mol
−1 nm−2) 
XYA L1-L3 0.32 5000 
XYA L1-L5 0.32 5000 
XYA L1-L2 0.32 1250 
XYA-LP1 L2-L6 0.47 1250 
XYA-LP1 L3-L9 0.47 1250 
XYA L4-L1 0.32 5000 
XYA L4-L3 0.32 5000 
LP1 L6-L7 0.47 1250 
LP1 L7-L8 0.47 1250 
LP1 L9-L10 0.47 1250 
SYB L13-L15 0.3 5000 
SYB L13-L16 0.47 5000 
SYB-XYA L13-L4 0.47 5000 
SYB L14-L15 0.47 5000 
SYB L14-L13 0.3 5000 
SYB L15-L17 0.32 5000 
SYB-LP3 L15-L28 0.47 1250 
SYB-LP2 L16-L21 0.47 1250 
LP2 L18-L19 0.47 1250 
LP2 L19-L20 0.47 1250 
LP2 L21-L18 0.47 5000 
LP2 L21-L22 0.47 1250 
LP2 L22-L23 0.47 1250 
LP2 L23-L24 0.47 1250 
LP3 L25-L28 0.47 1250 
LP3 L25-L26 0.47 1250 
LP3 L26-L27 0.47 1250 
LP3 L28-L29 0.3 1250 
LP3 L29-L30 0.47 1250 
LP3 L30-L31 0.47 1250 
LP3 L31-L32 0.47 1250 
LP1 (2-hydroxytetradecanoyl acid 14:0); LP2 (dodecanoyl acid decyl ester) ; LP3 (tetracanoyl 
acid decyl ester);  SYB (3-(acetyl amino)-3-deoxy-D-glucose); XYA(3-(acetyl amino)-3-deoxy-
D-glucose);   
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Table S4-2. Equilibrium angle and force constant values for the coarse grained Lipid A model of 
E. coli 
 
Angle θeq (degrees) Kangle(kJ mol
−1) 
L4-L3-L1 120 50 
L3-L1-L5 120 50 
L2-L6-L7 180 25 
L6-L7-L8 180 25 
L9-L10-L11 180 25 
L10-L11-L12 180 25 
L13-L4-L3 107 50 
L14-L15-L17 87 50 
L14-L13-L15 59 50 
L14-L15-L13 68 50 
L13-L16-L21 180 25 
L18-L19-L20 180 25 
L18-L21-L22 120 50 
L21-L22-L23 180 25 
L22-L23-L24 180 25 
L25-L26-L27 180 25 
L13-L15-L28 101 50 
L15-L28-L29 180 25 
L28-L29-L30 180 25 
















Table S4-3.  Equilibrium bond length and force constant values for the coarse grained core 
oligosaccharide model of E .coli 
  
Residue Bonds Rmin (nm) Kbond(kJ mol
−1 nm−2) 
GAL L1-L2 0.368 17000 
GAL L1-L3 0.291 17000 
GAL-2GA L1-L4 0.321 17000 
GAL L2-L3 0.298 17000 
2GA L4-L5 0.274 17000 
2GA L4-L6 0.372 17000 
2GA-2GL L4-L10 0.33 17000 
2GA L5-L6 0.268 17000 
GLC L7-L8 0.286 17000 
GLC L7-L9 0.372 17000 
GLC L8-L9 0.275 17000 
GLC-2GL L7-L11 0.352 17000 
2GL L10-L12 0.369 17000 
2GL L10-L11 0.281 17000 
2GL-3GL L10-L14 0.341 17000 
2GL L11-L12 0.33 17000 
3GL L14-L15 0.301 17000 
3GL L14-L13 0.365 17000 
3GL L13-L15 0.282 17000 
3GL-2HP L15-L23 0.365 17000 
HEP L16-L18 0.319 17000 
HEP L16-L19 0.234 17000 
HEP-2HP L16-L21 0.323 17000 
HEP L17-L18 0.287 17000 
HEP L18-L19 0.227 17000 
2HP L20-L22 0.308 17000 
2HP L20-L23 0.272 17000 
2HP-3HP L20-L28 0.306 17000 
2HP L21-L22 0.334 17000 
2HP L22-L23 0.387 17000 
2HP L23-L24 0.393 17000 
3HP L25-L27 0.267 17000 
3HP L25-L28 0.309 17000 
3HP-LKO L25-L34 0.293 17000 
3HP L26-L27 0.259 17000 
3HP L27-L28 0.316 17000 
3HP L28-L29 0.289 17000 
OKO L36-L35 0.258 17000 
OKO-3HP L35-L27 0.262 17000 
187 
 
3HP L27-L25 0.248 17000 
3HP L27-L28 0.258 17000 
3HP L28-L29 0.289 17000 
LKO L30-L31 0.239 17000 
3HP L28-L29 0.289 17000 
LKO L30-L31 0.239 17000 
LKO L30-L33 0.216 17000 
LKO L30-L34 0.248 17000 
LKO L32-L33 0.216 17000 
LKO L33-L34 0.258 17000 
LKO-OKO L34-L35 0.349 17000 
OKO L35-L36 0.233 17000 
OKO L35-L38 0.21 17000 
OKO L37-L38 0.284 17000 
OKO L37-L39 0.238 17000 
OKO L38-L39 0.242 17000 
    
LP1 (2-hydroxytetradecanoyl acid 14:0); LP2 (dodecanoyl acid decyl ester) ; LP3 (tetracanoyl 
acid decyl ester);  SYB (3-(acetyl amino)-3-deoxy-D-glucose); XYA(3-(acetyl amino)-3-deoxy-
D-glucose); LKO and OKO (3-deoxy-D-manno-oct-2-ulosonic acid) ; HEP  or HP (L-glycero-
D-manno heptose); GAL or GA (D-galactose); GLC or GL (D-glucose).  
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Table S4-4. Equilibrium angle and force constant values for the coarse -grained core 
oligosaccharide model of E. coli 
 
Angle θeq (degrees) Kangle(kJ mol
−1) 
L5-L1-L4 122 50 
L3-L1-L2 52 50 
L1-L3-L2 77 50 
L2-L1-L3 52 50 
L1-L4-L6 116 50 
L1-L4-L5 132 50 
L4-L5-L6 67 50 
L9-L8-L7 79 50 
L9-L7-L8 63 50 
L4-L10-L12 140 50 
L10-L11-L12 73 50 
L11-L12-L10 47 50 
L11-L7-L8 105 50 
L14-L15-L13 77 50 
L14-L13-L15 47 50 
L23-L22-L20 83 50 
L23-L20-L22 63 50 
L23-L22-L21 131 50 
L15-L23-L20 180 50 
L19-L18-L16 70 50 
L19-L18-L17 131 50 
L19-L16-L21 125 50 
L22-L20-L28 122 50 
L28-L27-L25 58 50 
L28-L27-L26 110 50 
L28-L25-L33 112 50 
L27-L28-L29 134 50 
L26-L27-L25 134 50 
L25-L34-L33 91 50 
L34-L33-L32 117 50 
L34-L30-L31 140 50 
L33-L30-L31 106 50 
L33-L34-L30 50 50 
L25-L34-L35 108 50 
L37-L39-L38 52 50 
L39-L37-L38 63 50 
L38-L35-L36 105 50 
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